Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Atrial Premature Complexes	4/106	3.71100922382165E-9	3.499481698063816E-6	0	0	780.1176470588235	15143.614096313533	CDH1;MYC;CTNNB1;RAC1
Pancreatic Neoplasm	5/665	4.0046983150845284E-8	1.8882152555623553E-5	0	0	96675.0	1646685.8177935767	CDH1;MYC;CTNNB1;RAC1;MUC4
synovial sarcoma	4/217	6.683017555363047E-8	2.100695184902451E-5	0	0	371.49295774647885	6137.476438406373	CDH1;CTNNB1;RAC1;MUC4
gallbladder neoplasm	3/45	1.0609283824093045E-7	2.4365412656267858E-5	0	0	712.6071428571429	11443.723398678585	CDH1;MYC;CTNNB1
Endometrial Carcinoma	5/840	1.291909472760756E-7	2.4365412656267858E-5	0	0	95800.0	1519577.1394321222	CDH1;MYC;CTNNB1;RAC1;MUC4
Noninfiltrating Intraductal Carcinoma	4/287	2.0530378274445922E-7	2.6036661940632674E-5	0	0	278.6148409893993	4290.327272475273	CDH1;MYC;CTNNB1;RAC1
ovarian neoplasm	5/938	2.2459258640353635E-7	2.6036661940632674E-5	0	0	95310.0	1459098.6744215954	CDH1;MYC;CTNNB1;RAC1;MUC4
Epithelioma	4/298	2.3871508048081333E-7	2.6036661940632674E-5	0	0	268.0408163265306	4087.085061465162	CDH1;MYC;CTNNB1;MUC4
Cutaneous Melanoma	4/301	2.4849412244506266E-7	2.6036661940632674E-5	0	0	265.2929292929293	4034.5341843771785	CDH1;MYC;CTNNB1;RAC1
Squamous cell carcinoma of esophagus	5/1023	3.4685502872030786E-7	3.270842920832503E-5	0	0	94885.0	1411353.5469747095	CDH1;MYC;CTNNB1;RAC1;MUC4
Mucoepidermoid Carcinoma	3/69	3.910300962858894E-7	3.3521943708872156E-5	0	0	452.9318181818182	6682.774044856407	CDH1;CTNNB1;MUC4
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	3/73	4.640464975888469E-7	3.6466320602190215E-5	0	0	426.9642857142857	6226.540189445254	CDH1;MYC;CTNNB1
Gastric Adenocarcinoma	4/383	6.520384167005157E-7	4.15844338642365E-5	0	0	207.02902374670185	2948.7479975116357	MYC;CTNNB1;RAC1;MUC4
Lung Neoplasms	5/1177	7.001858879466863E-7	4.15844338642365E-5	0	0	94115.0	1333790.2491950318	CDH1;MYC;CTNNB1;RAC1;MUC4
Adenomatous Polyposis Coli	4/392	7.155191104879294E-7	4.15844338642365E-5	0	0	202.1340206185567	2860.248447130688	CDH1;MYC;CTNNB1;RAC1
Adenocarcinoma of lung (disorder)	5/1187	7.304929802239526E-7	4.15844338642365E-5	0	0	94065.0	1329095.7647470406	CDH1;MYC;CTNNB1;RAC1;MUC4
Ovarian papillary adenocarcinoma	2/6	7.496663581039455E-7	4.15844338642365E-5	0	0	3331.8333333333335	46990.96982780607	CDH1;CTNNB1
Secondary malignant neoplasm of lymph node	5/1271	1.0288085936348446E-6	5.006772053376589E-5	0	0	93645.0	1291093.8345192499	CDH1;MYC;CTNNB1;RAC1;MUC4
Papillary cystic tumor	2/7	1.0494326119170083E-6	5.006772053376589E-5	0	0	2665.3333333333335	36694.33941065397	CDH1;CTNNB1
Adult Hepatocellular Carcinoma	3/97	1.0980832884471064E-6	5.006772053376589E-5	0	0	317.5691489361702	4357.6661931283625	CDH1;MYC;CTNNB1
Meningioma	4/438	1.1149757488961651E-6	5.006772053376589E-5	0	0	180.28571428571428	2471.118216254991	CDH1;MYC;CTNNB1;RAC1
Multiple Myeloma	5/1312	1.2061017198879385E-6	5.1697905538833E-5	0	0	93440.0	1273411.263540219	CDH1;MYC;CTNNB1;RAC1;MUC4
Epithelial ovarian cancer	5/1329	1.2864190659289538E-6	5.2743181703087106E-5	0	0	93355.0	1266234.3700073736	CDH1;MYC;CTNNB1;RAC1;MUC4
Renal Cell Carcinoma	5/1348	1.3811905111162548E-6	5.4269277165942844E-5	0	0	93260.0	1258316.5877906997	CDH1;MYC;CTNNB1;RAC1;MUC4
Lip and Oral Cavity Carcinoma	4/473	1.5157878661661976E-6	5.717551831178897E-5	0	0	166.5330490405117	2231.4721156530095	CDH1;MYC;CTNNB1;RAC1
Malignant neoplasm of mouth	4/492	1.7739131200934407E-6	6.207491210799939E-5	0	0	159.89344262295083	2117.360556719393	CDH1;MYC;CTNNB1;RAC1
Experimental Hepatoma	3/116	1.8849991632707706E-6	6.207491210799939E-5	0	0	263.92035398230087	3478.8880991641495	CDH1;MYC;CTNNB1
Liver Neoplasms, Experimental	3/116	1.8849991632707706E-6	6.207491210799939E-5	0	0	263.92035398230087	3478.8880991641495	CDH1;MYC;CTNNB1
Malignant Neoplasms	5/1438	1.9089845717200236E-6	6.207491210799939E-5	0	0	92810.0	1222209.2374179165	CDH1;MYC;CTNNB1;RAC1;MUC4
Hepatoma, Novikoff	3/119	2.0359523172044486E-6	6.399676783745984E-5	0	0	257.0560344827586	3368.6028545096315	CDH1;MYC;CTNNB1
Hepatoma, Morris	3/121	2.1409237382309173E-6	6.512551887586306E-5	0	0	252.67372881355934	3298.4718784829683	CDH1;MYC;CTNNB1
Uterine Cervical Neoplasm	3/124	2.3050295637403967E-6	6.792633995647482E-5	0	0	246.37190082644628	3198.010023527947	CDH1;MYC;CTNNB1
Biliary Tract Cancer	3/128	2.536551851599269E-6	7.248389078963971E-5	0	0	238.44	3072.2290454083222	CDH1;CTNNB1;MUC4
Neoplastic Cell Transformation	3/131	2.7199822447685716E-6	7.54395075534342E-5	0	0	232.81640625	2983.515520012688	CDH1;MYC;RAC1
Prostatic Neoplasms	5/1554	2.8150819517733544E-6	7.584635087206496E-5	0	0	92230.0	1178747.2843648423	CDH1;MYC;CTNNB1;RAC1;MUC4
Disease Exacerbation	3/144	3.61680055013445E-6	9.331193479949739E-5	0	0	211.2127659574468	2646.4792185944775	CDH1;MYC;CTNNB1
Medulloblastoma	4/590	3.661231800192368E-6	9.331193479949739E-5	0	0	132.48464163822527	1658.404444008355	CDH1;MYC;CTNNB1;RAC1
Liver and Intrahepatic Biliary Tract Carcinoma	4/607	4.10011582517825E-6	1.0174761113534445E-4	0	0	128.63681592039802	1595.6747829436063	CDH1;MYC;CTNNB1;RAC1
Invasive Carcinoma	3/154	4.426566677068125E-6	1.070321122173139E-4	0	0	197.12582781456953	2430.144790287872	CDH1;MYC;CTNNB1
Adenocarcinoma	5/1712	4.571046991102083E-6	1.0776243281523161E-4	0	0	91440.0	1124325.05137691	CDH1;MYC;CTNNB1;RAC1;MUC4
Intestinal Neoplasms	3/158	4.781476071133503E-6	1.0997394963607058E-4	0	0	192.0	2352.146161466479	MYC;CTNNB1;MUC4
Familial multiple trichoepitheliomata	3/161	5.059710229729296E-6	1.136025415865411E-4	0	0	188.3259493670886	2296.484544723399	CDH1;MYC;RAC1
Brain Neoplasms	4/646	5.2545784583629715E-6	1.1523412758689029E-4	0	0	120.57943925233644	1465.813194462124	CDH1;MYC;CTNNB1;RAC1
Sarcoma	4/658	5.654204656262886E-6	1.2117988615581595E-4	0	0	118.29357798165138	1429.3544454795108	MYC;CTNNB1;RAC1;MUC4
Papillary Renal Cell Carcinoma	3/169	5.853744196452491E-6	1.2266846171677108E-4	0	0	179.1777108433735	2158.809939640249	CDH1;MYC;MUC4
Malignant neoplasm of esophagus	4/673	6.18513968501863E-6	1.267953635428819E-4	0	0	115.55156950672645	1385.851683500778	CDH1;MYC;CTNNB1;MUC4
Liver Cirrhosis	4/683	6.559197022903528E-6	1.28279519889769E-4	0	0	113.79086892488954	1358.0533253108124	CDH1;MYC;CTNNB1;RAC1
Esophageal carcinoma	4/685	6.6359890335959165E-6	1.28279519889769E-4	0	0	113.44493392070484	1352.604269115957	CDH1;MYC;CTNNB1;MUC4
Malignant neoplasm of pancreas	5/1846	6.665637830963606E-6	1.28279519889769E-4	0	0	90770.0	1081846.3215118553	CDH1;MYC;CTNNB1;RAC1;MUC4
Pancreatic carcinoma	5/1869	7.091841816155751E-6	1.3192450641801858E-4	0	0	90655.0	1074856.9430951152	CDH1;MYC;CTNNB1;RAC1;MUC4
Squamous cell carcinoma	5/1876	7.225792393445081E-6	1.3192450641801858E-4	0	0	90620.0	1072746.2983199763	CDH1;MYC;CTNNB1;RAC1;MUC4
Pancreatic Ductal Adenocarcinoma	4/701	7.274734182117674E-6	1.3192450641801858E-4	0	0	110.74892395982783	1310.2819579732986	CDH1;MYC;RAC1;MUC4
Lobular Neoplasia	2/19	8.53534381334727E-6	1.492741880580986E-4	0	0	783.4509803921569	9143.887447340036	CDH1;MYC
Leukemogenesis	4/730	8.548044703220917E-6	1.492741880580986E-4	0	0	106.16528925619835	1238.9285409129745	CDH1;MYC;CTNNB1;RAC1
Malignant tumor of colon	5/2001	9.979370658494988E-6	1.711008460174686E-4	0	0	89995.0	1036291.5727383799	CDH1;MYC;CTNNB1;RAC1;MUC4
Malignant neoplasm of ovary	5/2026	1.0619205686360577E-5	1.788198386113933E-4	0	0	89870.0	1029267.3004927338	CDH1;MYC;CTNNB1;RAC1;MUC4
Colonic Neoplasms	4/778	1.1011742211688636E-5	1.8217671764249798E-4	0	0	99.33333333333333	1134.0438058182895	CDH1;MYC;CTNNB1;RAC1
Blast Phase	3/214	1.1889899989994587E-5	1.9180948603222717E-4	0	0	140.64454976303318	1594.8840553044827	CDH1;MYC;RAC1
Tumor Progression	5/2090	1.2407741274550699E-5	1.9180948603222717E-4	0	0	89550.0	1011663.3630502248	CDH1;MYC;CTNNB1;RAC1;MUC4
Colon Carcinoma	5/2091	1.2437482106668096E-5	1.9180948603222717E-4	0	0	89545.0	1011392.4983408066	CDH1;MYC;CTNNB1;RAC1;MUC4
Invasive Ductal Breast Carcinoma	3/218	1.2568629137597922E-5	1.9180948603222717E-4	0	0	138.0	1557.2343107413888	CDH1;MYC;RAC1
Malignant neoplasm of liver	4/805	1.2611016048778456E-5	1.9180948603222717E-4	0	0	95.8501872659176	1081.2801958535094	CDH1;MYC;CTNNB1;RAC1
Stomach Neoplasms	4/835	1.4584478685281327E-5	2.166652943070455E-4	0	0	92.24548736462094	1027.2044857469482	CDH1;MYC;CTNNB1;MUC4
Hepatitis B	4/839	1.4864009045433062E-5	2.166652943070455E-4	0	0	91.78443113772455	1020.3278487298741	CDH1;MYC;CTNNB1;RAC1
Solid Neoplasm	4/840	1.4934511272489882E-5	2.166652943070455E-4	0	0	91.66985645933015	1018.620395578649	CDH1;MYC;RAC1;MUC4
Tumor Initiation	3/234	1.554008287277043E-5	2.2024871070872016E-4	0	0	128.33766233766235	1420.9658757382942	CDH1;MYC;RAC1
Undifferentiated carcinoma	3/237	1.614445605998208E-5	2.2024871070872016E-4	0	0	126.67307692307692	1397.702350743328	CDH1;MYC;CTNNB1
Ovarian Carcinoma	5/2203	1.6148855131934056E-5	2.2024871070872016E-4	0	0	88985.0	981830.3597209944	CDH1;MYC;CTNNB1;RAC1;MUC4
Malignant Uterine Corpus Neoplasm	2/26	1.621089789622037E-5	2.2024871070872016E-4	0	0	554.75	6118.796435190915	CTNNB1;RAC1
Endometrial Neoplasms	3/238	1.6349321049427795E-5	2.2024871070872016E-4	0	0	126.12765957446808	1390.0938251823798	CDH1;MYC;CTNNB1
Meningioma, benign, no ICD-O subtype	3/241	1.697423547252967E-5	2.2518072197772702E-4	0	0	124.51890756302521	1367.6925106884028	CDH1;MYC;RAC1
Gastric lymphoma	2/27	1.750603176699575E-5	2.2518072197772702E-4	0	0	532.5333333333333	5832.818995426615	CDH1;MYC
Myeloid Leukemia, Chronic	4/876	1.7642951712055296E-5	2.2518072197772702E-4	0	0	87.72018348623853	960.1126883030512	CDH1;MYC;CTNNB1;RAC1
Non-Small Cell Lung Carcinoma	5/2243	1.7670597482875714E-5	2.2518072197772702E-4	0	0	88785.0	971628.2770144513	CDH1;MYC;CTNNB1;RAC1;MUC4
Malignant tumor of cervix	4/884	1.8291401536476013E-5	2.2998388865195843E-4	0	0	86.88636363636364	947.8502457624231	CDH1;MYC;CTNNB1;RAC1
Primary malignant neoplasm of lung	5/2268	1.8678488934662705E-5	2.3176072454456485E-4	0	0	88660.0	965342.3169049952	CDH1;MYC;CTNNB1;RAC1;MUC4
Paget Disease Extramammary	2/29	2.0245119936613775E-5	2.4475830897726655E-4	0	0	493.037037037037	5328.545495992294	CDH1;CTNNB1
Dysgerminoma	2/29	2.0245119936613775E-5	2.4475830897726655E-4	0	0	493.037037037037	5328.545495992294	CDH1;CTNNB1
Neuroendocrine Tumors	3/257	2.0575594860582056E-5	2.456048854877073E-4	0	0	116.58070866141732	1258.0696306948323	MYC;CTNNB1;MUC4
Ulcerative Colitis	4/915	2.0973185052932295E-5	2.472214188114394E-4	0	0	83.79363336992316	902.6472942276193	CDH1;CTNNB1;RAC1;MUC4
Squamous cell carcinoma of the head and neck	4/934	2.2755333425706026E-5	2.6491702988198495E-4	0	0	82.0	876.638302307372	CDH1;MYC;CTNNB1;RAC1
Sebaceous Adenocarcinoma	2/31	2.3182535919118327E-5	2.6659916306986074E-4	0	0	458.98850574712645	4898.376430167524	CDH1;CTNNB1
Stomach Carcinoma	5/2378	2.3674209628241405E-5	2.689732491497788E-4	0	0	88110.0	938470.5623976137	CDH1;MYC;CTNNB1;RAC1;MUC4
Malignant neoplasm of stomach	5/2398	2.468752579540694E-5	2.7714686696510407E-4	0	0	88010.0	933716.789522213	CDH1;MYC;CTNNB1;RAC1;MUC4
cervical cancer	4/965	2.5902134415850416E-5	2.873613265193758E-4	0	0	79.2258064516129	836.7184131902451	CDH1;MYC;CTNNB1;RAC1
Malignant neoplasm of lung	5/2449	2.742924293612975E-5	2.9694455760679835E-4	0	0	87755.0	921769.8193765228	CDH1;MYC;CTNNB1;RAC1;MUC4
Anaplasia	3/283	2.744904570310974E-5	2.9694455760679835E-4	0	0	105.61607142857143	1109.304519917231	CDH1;MYC;RAC1
melanoma	5/2454	2.771062679681681E-5	2.9694455760679835E-4	0	0	87730.0	920611.8254566668	CDH1;MYC;CTNNB1;RAC1;MUC4
Carcinoma of lung	5/2476	2.897628447013404E-5	3.070183848914202E-4	0	0	87620.0	915544.2573910023	CDH1;MYC;CTNNB1;RAC1;MUC4
Adenoma	4/1000	2.9832436971569384E-5	3.1257764515766587E-4	0	0	76.3012048192771	795.0520127199089	CDH1;MYC;CTNNB1;MUC4
Pituitary Adenoma	3/294	3.0762505798011155E-5	3.187806919508189E-4	0	0	101.56701030927834	1055.2014007479095	CDH1;MYC;CTNNB1
Adenocarcinoma of large intestine	3/297	3.170994352977021E-5	3.2502692118014466E-4	0	0	100.51530612244898	1041.226019439578	CDH1;MYC;CTNNB1
Adenocarcinoma Of Esophagus	3/299	3.235217213126368E-5	3.27807746583973E-4	0	0	99.82601351351352	1032.0841228557276	CDH1;MYC;RAC1
Hereditary Diffuse Gastric Cancer	3/300	3.2676487994584795E-5	3.27807746583973E-4	0	0	99.48484848484848	1027.564550845814	CDH1;MYC;CTNNB1
Osteosarcoma of bone	4/1042	3.511598530642272E-5	3.485723594100697E-4	0	0	73.05202312138728	749.2839435474784	MYC;CTNNB1;RAC1;MUC4
Colorectal Neoplasms	4/1073	3.944059253122116E-5	3.8742165371814113E-4	0	0	70.8175865294668	718.1409623182429	CDH1;MYC;CTNNB1;RAC1
Kaposi Sarcoma	3/323	4.074117576479771E-5	3.9607143037323955E-4	0	0	92.2265625	932.251113652132	MYC;CTNNB1;RAC1
Osteosarcoma	4/1103	4.3991457340192755E-5	4.2204608318308664E-4	0	0	68.77525022747953	689.9199607681313	MYC;CTNNB1;RAC1;MUC4
Cervix carcinoma	4/1105	4.4308125381893504E-5	4.2204608318308664E-4	0	0	68.64305177111717	688.1014598626745	CDH1;MYC;CTNNB1;RAC1
High Grade Lymphoma (neoplasm)	2/43	4.496523613857176E-5	4.2402217678673166E-4	0	0	324.4552845528455	3247.674396403277	CDH1;MYC
Chronic Lymphocytic Leukemia	4/1120	4.673750221346673E-5	4.312324590118246E-4	0	0	67.66666666666667	674.7018750237348	CDH1;MYC;CTNNB1;RAC1
Medullomyoblastoma	2/44	4.710174260680587E-5	4.312324590118246E-4	0	0	316.7142857142857	3155.4879486634554	MYC;CTNNB1
Melanotic medulloblastoma	2/44	4.710174260680587E-5	4.312324590118246E-4	0	0	316.7142857142857	3155.4879486634554	MYC;CTNNB1
Malignant neoplasm of urinary bladder	4/1144	5.082882184356295E-5	4.6088056729307557E-4	0	0	66.15789473684211	654.1062150243891	CDH1;MYC;CTNNB1;RAC1
Carcinoma of bladder	4/1162	5.4067742726854096E-5	4.855798227754611E-4	0	0	65.06735751295336	639.3045381142485	CDH1;MYC;CTNNB1;RAC1
Metaplasia	2/51	6.343848911664257E-5	5.643631626131504E-4	0	0	271.3741496598639	2622.950505962369	CDH1;CTNNB1
Bladder Neoplasm	4/1217	6.491948892110664E-5	5.721409163794725E-4	0	0	61.935696619950534	597.2064501305068	CDH1;MYC;CTNNB1;RAC1
Desmoplastic Medulloblastoma	2/52	6.596944588909246E-5	5.760109951242054E-4	0	0	265.93333333333334	2559.9590632869204	MYC;CTNNB1
Prostate cancer, familial	2/53	6.854964198711411E-5	5.895722917301377E-4	0	0	260.70588235294116	2499.635583784046	CDH1;MYC
Invasive carcinoma of breast	3/385	6.877301388156431E-5	5.895722917301377E-4	0	0	77.01439790575917	738.159832609793	CDH1;MYC;RAC1
Cardiomyopathy, Familial Idiopathic	3/388	7.038147333165469E-5	5.979254896554088E-4	0	0	76.40259740259741	730.5295848885028	CDH1;MYC;RAC1
Parathyroid Neoplasms	2/56	7.658551744667382E-5	6.448227049304769E-4	0	0	246.1851851851852	2333.122250320546	MYC;CTNNB1
Intestinal Cancer	2/58	8.218869169335486E-5	6.858755421843684E-4	0	0	237.36904761904762	2232.81024591821	MYC;CTNNB1
Malignant neoplasm of kidney	3/421	8.973964296417244E-5	7.4232002908083E-4	0	0	70.25239234449761	654.6537982992834	CDH1;MYC;CTNNB1
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	2/61	9.096204162238498E-5	7.458887413035568E-4	0	0	225.26553672316385	2096.111196622331	MYC;CTNNB1
Hereditary Malignant Neoplasm	2/62	9.398472243329423E-5	7.575007970478329E-4	0	0	221.5	2053.831797040215	CDH1;MYC
Low grade glioma	2/62	9.398472243329423E-5	7.575007970478329E-4	0	0	221.5	2053.831797040215	CDH1;MYC
Prostate carcinoma	5/3145	9.588951957269054E-5	7.663035335342981E-4	0	0	84275.0	779738.7511416964	CDH1;MYC;CTNNB1;RAC1;MUC4
Cirrhosis	3/433	9.756439248740037E-5	7.731363202993156E-4	0	0	68.25	630.2886109190574	CDH1;CTNNB1;RAC1
Adult Medulloblastoma	2/64	1.001773411518344E-4	7.872269392181654E-4	0	0	214.33333333333334	1973.7031884981131	MYC;CTNNB1
Precancerous Conditions	3/446	1.065345631350221E-4	8.302652317051723E-4	0	0	66.20316027088036	605.563027218487	CDH1;MYC;CTNNB1
Cervical Adenocarcinoma	2/67	1.098341891953128E-4	8.489642656654095E-4	0	0	204.4102564102564	1863.5140133125917	CDH1;CTNNB1
Malignant neoplasm of prostate	5/3239	1.111125993114245E-4	8.518632613875879E-4	0	0	83805.0	763041.7143986315	CDH1;MYC;CTNNB1;RAC1;MUC4
Cholangiocarcinoma	3/455	1.1305258672553766E-4	8.536125857840565E-4	0	0	64.85508849557522	589.3808299693846	CDH1;MYC;MUC4
Alveolar rhabdomyosarcoma	2/68	1.1315119111665648E-4	8.536125857840565E-4	0	0	201.3030303030303	1829.1974888825955	MYC;RAC1
Colorectal Cancer	5/3298	1.2161472770325453E-4	9.101800652711827E-4	0	0	83510.0	752813.6285868824	CDH1;MYC;CTNNB1;RAC1;MUC4
Familial primary gastric lymphoma	2/72	1.269090658981553E-4	9.423247963933893E-4	0	0	189.76190476190476	1702.5513515192338	CDH1;MYC
Marginal Zone B-Cell Lymphoma	2/74	1.340817157708724E-4	9.87805140405724E-4	0	0	184.47222222222223	1644.9500813633047	CDH1;MYC
Breast Fibrocystic Disease	2/75	1.37741416915363E-4	0.0010069004352805217	0	0	181.93607305936072	1617.4357816575248	MYC;RAC1
Infection	3/492	1.426044404760556E-4	0.0010344306720686187	0	0	59.83435582822086	529.8593033179021	CDH1;MYC;CTNNB1
Pleural Effusion, Malignant	2/78	1.4901384711723037E-4	0.0010687177189726781	0	0	174.7280701754386	1539.6113796153343	MYC;RAC1
Renal carcinoma	3/500	1.495978143206718E-4	0.0010687177189726781	0	0	58.84708249496982	518.299215942201	CDH1;MYC;CTNNB1
Luminal B Breast Carcinoma	2/80	1.5677309135435125E-4	0.0011115565800537835	0	0	170.23076923076923	1491.3425854820227	CDH1;MYC
Salivary Gland Neoplasms	2/82	1.6472762985412622E-4	0.0011592399623316493	0	0	165.95833333333334	1445.6990838624515	CDH1;CTNNB1
Soft Tissue Neoplasms	2/84	1.7287734408582645E-4	0.0012075802627624765	0	0	161.89430894308944	1402.4787757621705	CTNNB1;MUC4
Hepatocarcinogenesis	3/527	1.7485819782631044E-4	0.0012124358863986084	0	0	55.73759541984733	482.21576933150095	CDH1;MYC;CTNNB1
Multiple tumors	2/87	1.854676106804791E-4	0.0012575128540334574	0	0	156.15686274509804	1341.7981898546207	MYC;CTNNB1
Hemangiosarcoma	2/87	1.854676106804791E-4	0.0012575128540334574	0	0	156.15686274509804	1341.7981898546207	MYC;CTNNB1
Adrenal Gland Neoplasms	2/87	1.854676106804791E-4	0.0012575128540334574	0	0	156.15686274509804	1341.7981898546207	MYC;CTNNB1
Liver carcinoma	5/3593	1.8669331873243268E-4	0.0012575128540334574	0	0	82035.0	704356.0616373493	CDH1;MYC;CTNNB1;RAC1;MUC4
Prolactinoma	2/91	2.0293664218794575E-4	0.0013572287488172541	0	0	149.10861423220973	1267.8133987163728	CDH1;MYC
Mucinous Adenocarcinoma	2/93	2.1196318119144034E-4	0.0013977711878568409	0	0	145.8168498168498	1233.4790185692234	MYC;MUC4
Childhood Medulloblastoma	2/93	2.1196318119144034E-4	0.0013977711878568409	0	0	145.8168498168498	1233.4790185692234	MYC;CTNNB1
Limb ischemia	2/95	2.211842446071416E-4	0.0014422374953398146	0	0	142.66666666666666	1200.7560712010697	CTNNB1;RAC1
Papillary thyroid carcinoma	3/571	2.217650443523575E-4	0.0014422374953398146	0	0	51.30369718309859	431.66377218968137	CDH1;MYC;CTNNB1
Malignant neoplasm of endometrium	3/577	2.2873712753787578E-4	0.0014773911730699787	0	0	50.751742160278745	425.4486636889472	CDH1;CTNNB1;MUC4
Uterine Corpus Cancer	3/579	2.3109272868631958E-4	0.001482451994225846	0	0	50.5703125	423.40962587933564	CDH1;CTNNB1;MUC4
Leukemia, Myelocytic, Acute	4/1703	2.441862873036922E-4	0.0015558626278877146	0	0	43.07474985285462	358.2776413283853	CDH1;MYC;CTNNB1;RAC1
Liver diseases	3/606	2.644669231709178E-4	0.0016737738828870837	0	0	48.23880597014925	397.38136417178123	CTNNB1;RAC1;MUC4
Neoplasm Metastasis	5/3920	2.886525814572079E-4	0.0018146625620943137	0	0	80400.0	655283.0533564005	CDH1;MYC;CTNNB1;RAC1;MUC4
Conventional (Clear Cell) Renal Cell Carcinoma	3/631	2.9805405573121664E-4	0.0018577885409979842	0	0	46.25875796178344	375.5394999916937	CDH1;MYC;MUC4
Triple Negative Breast Neoplasms	3/632	2.994526598427292E-4	0.0018577885409979842	0	0	46.18282988871224	374.7068941903835	CDH1;MYC;RAC1
Esophageal Neoplasms	3/637	3.0651023060555583E-4	0.0018891447546473148	0	0	45.806782334384856	370.58875247917877	CDH1;MYC;CTNNB1
Carcinoma, Endometrioid	2/114	3.1846364469203213E-4	0.0019250719034909379	0	0	118.35119047619048	952.964050212754	CDH1;CTNNB1
Neuroectodermal Tumor, Primitive	2/114	3.1846364469203213E-4	0.0019250719034909379	0	0	118.35119047619048	952.964050212754	MYC;CTNNB1
leiomyosarcoma	2/114	3.1846364469203213E-4	0.0019250719034909379	0	0	118.35119047619048	952.964050212754	CDH1;MYC
Carcinoma, Cribriform	2/115	3.2406770804292506E-4	0.001934150941041002	0	0	117.29793510324484	942.4370732555304	MYC;CTNNB1
Carcinoma, Granular Cell	2/115	3.2406770804292506E-4	0.001934150941041002	0	0	117.29793510324484	942.4370732555304	MYC;CTNNB1
Condition, Preneoplastic	2/116	3.297200775944884E-4	0.001955509642588695	0	0	116.26315789473684	932.1127225065889	CDH1;MYC
Adenocarcinoma, Basal Cell	2/117	3.354207386174795E-4	0.00197688597822677	0	0	115.2463768115942	921.9854062293039	MYC;CTNNB1
Carcinogenesis	5/4065	3.4616887415333354E-4	0.002027560548612382	0	0	79675.0	634896.9163675458	CDH1;MYC;CTNNB1;RAC1;MUC4
Small cell carcinoma of lung	3/673	3.605636613548336E-4	0.002096725423862886	0	0	43.264925373134325	342.99749358159903	CDH1;MYC;RAC1
Adenocarcinoma, Oxyphilic	2/122	3.64647899802241E-4	0.002096725423862886	0	0	110.41666666666667	874.1221903877367	MYC;CTNNB1
Gastrointestinal Neoplasms	2/122	3.64647899802241E-4	0.002096725423862886	0	0	110.41666666666667	874.1221903877367	CDH1;CTNNB1
MYELODYSPLASTIC SYNDROME	3/683	3.76611679131327E-4	0.0021523928086111597	0	0	42.606617647058826	335.9231821138624	CDH1;MYC;RAC1
Adenocarcinoma, Tubular	2/125	3.827627510597186E-4	0.002174369121983823	0	0	107.70731707317073	847.4514255078432	MYC;CTNNB1
Hereditary Nonpolyposis Colorectal Cancer	2/128	4.013110322793061E-4	0.0022660856493376385	0	0	105.12698412698413	822.1743620524082	CDH1;CTNNB1
Cleft palate, isolated	2/129	4.0759004177445227E-4	0.0022767725127753207	0	0	104.29396325459318	814.0403198886481	MYC;CTNNB1
leukemia	4/1941	4.080324015472208E-4	0.0022767725127753207	0	0	37.29065565307176	291.0223913085041	CDH1;MYC;CTNNB1;RAC1
Hyperactive behavior	3/709	4.205066020160998E-4	0.002332574857065777	0	0	40.98229461756374	318.59842297443396	CDH1;MYC;RAC1
Mouth Neoplasms	2/132	4.2671561135096327E-4	0.002339493148278828	0	0	101.87179487179488	790.4632698373591	MYC;CTNNB1
precancerous lesions	2/132	4.2671561135096327E-4	0.002339493148278828	0	0	101.87179487179488	790.4632698373591	CDH1;CTNNB1
Thyroid carcinoma	3/721	4.418448698816635E-4	0.00240007438532337	0	0	40.272284122562674	311.08534120913214	CDH1;MYC;CTNNB1
Alzheimer's Disease	4/1982	4.4285571903103537E-4	0.00240007438532337	0	0	36.43478260869565	281.35910232680897	CDH1;MYC;CTNNB1;RAC1
Astrocytoma	3/741	4.789599834730566E-4	0.0025809100823719565	0	0	39.140243902439025	299.183856183359	CDH1;MYC;RAC1
Lymphatic Metastasis	2/142	4.935889129934685E-4	0.0026337821541160813	0	0	94.54761904761905	719.867375469436	CDH1;MUC4
Endometriosis	3/749	4.94357838047239E-4	0.0026337821541160813	0	0	38.7044235924933	294.6277846607735	CDH1;CTNNB1;MUC4
Nerve Degeneration	2/145	5.145857959825348E-4	0.0027109184671035213	0	0	92.55011655011656	700.8032040488963	CDH1;CTNNB1
Thrombocythemia, Essential	2/145	5.145857959825348E-4	0.0027109184671035213	0	0	92.55011655011656	700.8032040488963	MYC;CTNNB1
Monosomy	2/147	5.288230668011627E-4	0.002770445288852758	0	0	91.26436781609195	688.5765723657122	MYC;CTNNB1
Monoclonal Gammopathy of Undetermined Significance	2/150	5.505377030005599E-4	0.0028682710161852375	0	0	89.40090090090091	670.919352240136	CDH1;MYC
Cervical Squamous Cell Carcinoma	2/153	5.726824628379199E-4	0.0029349976220443396	0	0	87.61147902869757	654.0353875035723	CDH1;MYC
Squamous cell carcinoma of tongue	2/153	5.726824628379199E-4	0.0029349976220443396	0	0	87.61147902869757	654.0353875035723	CDH1;MYC
Primary Effusion Lymphoma	2/153	5.726824628379199E-4	0.0029349976220443396	0	0	87.61147902869757	654.0353875035723	MYC;CTNNB1
Breast Cancer, Familial	2/154	5.80159564004929E-4	0.002957245777603503	0	0	87.03070175438596	648.5708380665291	CDH1;MYC
Abnormality of metabolism/homeostasis	2/155	5.876843981730204E-4	0.0029794967068664424	0	0	86.45751633986929	643.1851729913229	CDH1;CTNNB1
Sporadic Breast Carcinoma	2/159	6.182607700834902E-4	0.0031177535090306484	0	0	84.23779193205945	622.3993689653735	CDH1;MYC
Malignant neoplasm of brain	2/166	6.73603752374296E-4	0.0033608906798357737	0	0	80.61382113821138	588.7121370238503	MYC;CTNNB1
invasive cancer	2/166	6.73603752374296E-4	0.0033608906798357737	0	0	80.61382113821138	588.7121370238503	MYC;CTNNB1
Glioma	4/2211	6.792001219322706E-4	0.003365671856999908	0	0	32.23923878568192	235.17218177866434	CDH1;MYC;CTNNB1;RAC1
Transitional cell carcinoma of bladder	2/167	6.817002382682741E-4	0.003365671856999908	0	0	80.12121212121212	584.1573903490295	CDH1;CTNNB1
Cleft upper lip	2/169	6.980358230036179E-4	0.0034106102647275213	0	0	79.15369261477046	575.228891737348	CDH1;MYC
Cyst	2/169	6.980358230036179E-4	0.0034106102647275213	0	0	79.15369261477046	575.228891737348	CDH1;RAC1
Prostatic Intraepithelial Neoplasias	2/174	7.397060107866649E-4	0.003585799055190722	0	0	76.83333333333333	553.9113025181134	CDH1;MYC
Mammary Tumorigenesis	2/176	7.567062693350516E-4	0.003585799055190722	0	0	75.94252873563218	545.763671063253	MYC;CTNNB1
Mucosa-Associated Lymphoid Tissue Lymphoma	2/176	7.567062693350516E-4	0.003585799055190722	0	0	75.94252873563218	545.763671063253	CDH1;MYC
Carcinomatosis	2/176	7.567062693350516E-4	0.003585799055190722	0	0	75.94252873563218	545.763671063253	CDH1;MYC
Well Differentiated Oligodendroglioma	2/176	7.567062693350516E-4	0.003585799055190722	0	0	75.94252873563218	545.763671063253	CDH1;RAC1
Anaplastic thyroid carcinoma	2/176	7.567062693350516E-4	0.003585799055190722	0	0	75.94252873563218	545.763671063253	MYC;CTNNB1
Intrahepatic Cholangiocarcinoma	2/177	7.652775223091702E-4	0.003608283517687737	0	0	75.5047619047619	541.7672051446157	CDH1;MUC4
Virus Diseases	3/875	7.809952310219924E-4	0.003664072153501188	0	0	32.89506880733945	235.3622934283183	CDH1;MYC;CTNNB1
Hepatitis, Chronic	2/183	8.176998514647321E-4	0.003779857646721776	0	0	72.97974217311234	518.8140977469528	CDH1;MYC
Neoplasm Invasiveness	2/183	8.176998514647321E-4	0.003779857646721776	0	0	72.97974217311234	518.8140977469528	CDH1;CTNNB1
oligodendroglioma	2/183	8.176998514647321E-4	0.003779857646721776	0	0	72.97974217311234	518.8140977469528	CDH1;RAC1
Ulcer	2/184	8.266025718921549E-4	0.003802371830703912	0	0	72.57509157509158	515.1515384827694	CDH1;RAC1
Carcinoma, Spindle-Cell	2/188	8.626862493694165E-4	0.0039490928793949505	0	0	71.0	500.9376238661725	CDH1;MYC
Crohn Disease	3/912	8.819126257300511E-4	0.004017601961659121	0	0	31.495049504950494	221.51783457701202	CDH1;RAC1;MUC4
Mammary Neoplasms	4/2387	9.157418999191572E-4	0.004151656786652717	0	0	29.562736046999582	206.8142793804646	CDH1;MYC;CTNNB1;RAC1
Disseminated Malignant Neoplasm	2/195	9.276507005693903E-4	0.004185524452808302	0	0	68.40069084628671	477.63212634540446	MYC;MUC4
Breast Carcinoma	5/4963	9.395138165520207E-4	0.004218864423850264	0	0	75185.0	524050.5798563536	CDH1;MYC;CTNNB1;RAC1;MUC4
Malignant neoplasm of gallbladder	2/203	0.0010047235215473135	0.004469123966127909	0	0	65.65174129353234	453.1967851814795	CDH1;MYC
Melanocytic nevus	2/203	0.0010047235215473135	0.004469123966127909	0	0	65.65174129353234	453.1967851814795	MYC;RAC1
Papilloma	2/204	0.0010145693548244859	0.004470742530838739	0	0	65.32343234323433	450.29343070918674	MYC;RAC1
Anaplastic carcinoma	2/204	0.0010145693548244859	0.004470742530838739	0	0	65.32343234323433	450.29343070918674	CDH1;MYC
Squamous cell carcinoma of skin	2/205	0.0010244621906275791	0.004471219268389527	0	0	64.99835796387521	447.4218841511589	MYC;RAC1
Thymoma	2/205	0.0010244621906275791	0.004471219268389527	0	0	64.99835796387521	447.4218841511589	CDH1;MYC
Malignant neoplasm of breast	5/5054	0.0010289019949528391	0.004471219268389527	0	0	74730.0	514087.32919616136	CDH1;MYC;CTNNB1;RAC1;MUC4
Polycythemia Vera	2/207	0.0010443888124217202	0.004517700229879276	0	0	64.35772357723577	441.7722300562864	MYC;CTNNB1
Adenoid Cystic Carcinoma	2/208	0.001054422569208539	0.004540276177002978	0	0	64.042071197411	438.993155382923	CDH1;CTNNB1
Trisomy	2/209	0.0010645032704783251	0.004562848109368457	0	0	63.729468599033815	436.243953823342	MYC;CTNNB1
Degenerative polyarthritis	3/976	0.0010757940042495872	0.004590378941209777	0	0	29.32476875642343	200.42588797347844	MYC;CTNNB1;RAC1
Carcinoid Tumor	2/213	0.0011052952306030918	0.004695015326390611	0	0	62.5086887835703	425.53682530252837	MYC;CTNNB1
Carcinoma	2/216	0.0011363814062815842	0.004783962795194348	0	0	61.62305295950156	417.79852314077834	CDH1;MYC
Adenocarcinoma of prostate	2/216	0.0011363814062815842	0.004783962795194348	0	0	61.62305295950156	417.79852314077834	MYC;CTNNB1
Gastrointestinal Carcinoid Tumor	2/225	0.0012321670941094337	0.005164149198867538	0	0	59.10911808669656	395.9708468563215	CTNNB1;RAC1
Primary malignant neoplasm	3/1032	0.0012664888563322832	0.005284508812041341	0	0	27.64723032069971	184.4486875007385	CDH1;MYC;RAC1
Endometrioma	2/229	0.0012759532799700437	0.005300546004457053	0	0	58.055800293685756	386.8874357325693	MYC;CTNNB1
Ductal Carcinoma	2/230	0.0012870164618833987	0.005323054927877391	0	0	57.79824561403509	384.6720945517519	CDH1;MYC
Metastasis from malignant tumor of prostate	2/232	0.0013092826871163043	0.005391500322928712	0	0	57.289855072463766	380.3058618831463	CDH1;MYC
Gallbladder Carcinoma	2/233	0.0013204857013043706	0.005413991375347919	0	0	57.03896103896104	378.1543744765272	MYC;CTNNB1
Epstein-Barr Virus Infections	2/234	0.0013317352973104383	0.005435530760619451	0	0	56.79022988505747	376.0235847008631	CDH1;MYC
Microcephaly	2/235	0.00134303146047119	0.005435530760619451	0	0	56.543633762517885	373.9132078716041	CTNNB1;RAC1
Hepatoblastoma	2/235	0.00134303146047119	0.005435530760619451	0	0	56.543633762517885	373.9132078716041	MYC;CTNNB1
Metastatic Prostate Carcinoma	2/241	0.0014117855419426382	0.0056893750685978964	0	0	55.10739191073919	361.6643042404139	CDH1;MYC
Kidney Neoplasm	2/246	0.0014703585566770649	0.0057237420720174705	0	0	53.96448087431694	351.9697809769996	CDH1;CTNNB1
Malignant neoplasm of cecum	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Bile Reflux	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	MUC4
Microcystic stromal tumor	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Giant cell carcinoma of lung	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	MYC
Small intestine carcinoma	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Cecal Neoplasms	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Childhood Hepatocellular Carcinoma	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Serous cystadenoma, borderline malignancy	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	MYC
Ossifying fibromyxoid tumor	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	MUC4
Abnormality of bone marrow cell morphology	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	MYC
Alpha fetoprotein abnormal	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
Elevated alpha-fetoprotein	1/6	0.0014992198216206949	0.0057237420720174705	0	0	999.5	6499.5590198897235	CTNNB1
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	2/249	0.0015060592050701526	0.005726668670891749	0	0	53.30094466936572	346.3633347491524	CDH1;RAC1
Skin Neoplasms	2/256	0.0015909823045153846	0.006025286398224931	0	0	51.813648293963254	333.8562506370787	CTNNB1;RAC1
Adenoma of large intestine	2/258	0.0016156625068345157	0.006094278975779793	0	0	51.403645833333336	330.4231589872143	CDH1;MYC
Sjogren's Syndrome	2/260	0.0016405275906497545	0.006138958404693327	0	0	51.0	327.04960675052496	MYC;MUC4
Lymphoma, T-Cell, Cutaneous	2/260	0.0016405275906497545	0.006138958404693327	0	0	51.0	327.04960675052496	MYC;RAC1
Refractory anemias	2/266	0.0017162309761919769	0.006343185667620997	0	0	49.82575757575758	317.27172391133195	RAC1;MUC4
Adenocarcinoma of colon	2/267	0.001729009658706438	0.006343185667620997	0	0	49.63522012578616	315.69024897807327	CDH1;MYC
Ataxic cerebral palsy	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CTNNB1
Fibromatosis, Abdominal	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CTNNB1
Fundic gland polyp	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CTNNB1
Gastrointestinal polyps	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CTNNB1
OTOFACIOCERVICAL SYNDROME 1	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CDH1
Adamantinous Craniopharyngioma	1/7	0.0017489165149326186	0.006343185667620997	0	0	832.875	5287.722499803602	CTNNB1
Cytomegalovirus Infections	2/270	0.0017676221921104718	0.006386466387586877	0	0	49.07213930348259	311.0251090268616	CDH1;CTNNB1
Rectal Carcinoma	2/276	0.0018460901491804908	0.006644515307928255	0	0	47.982968369829685	302.0376860902479	MYC;CTNNB1
Pheochromocytoma	2/280	0.0018993215325094983	0.006683139418632729	0	0	47.28297362110312	296.28733747366	MYC;RAC1
polyps	2/285	0.001966893481701103	0.006683139418632729	0	0	46.43580683156655	289.35543817387884	CDH1;CTNNB1
RETINITIS PIGMENTOSA 9	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Exudative vitreoretinopathy 1	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CTNNB1
Secondary malignant neoplasm of ovary	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Endometrial stromal sarcoma, high grade	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CTNNB1
Brenner Tumor	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Gastrointestinal lymphoma	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Grade III Chondrosarcoma	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Nephrogenic rest, intralobar	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CTNNB1
Chronic cholecystitis	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Polycystic Kidney, Type 1 Autosomal Dominant Disease	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Chronic rhinosinusitis with nasal polyps	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MUC4
Cleft palate and bilateral cleft lip	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Intestinal adenocarcinoma	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	MYC
Krukenberg Tumor	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Distichiasis	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Apocrine Carcinoma	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CDH1
Endometrial Stromal Tumors	1/8	0.001998563431658992	0.006683139418632729	0	0	713.8571428571429	4436.855317641398	CTNNB1
Colorectal Carcinoma	4/2931	0.002032617333061274	0.006759089369430832	0	0	23.32490604714725	144.57782047599687	CDH1;MYC;CTNNB1;RAC1
Fanconi Anemia	2/290	0.002035611220486062	0.006759089369430832	0	0	45.61805555555556	282.6932268321044	CDH1;RAC1
Neoplasms	3/1236	0.002142441024743809	0.0070888487239768845	0	0	22.824817518248175	140.27697883857357	MYC;CTNNB1;RAC1
Atypical polypoid adenomyoma	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	CTNNB1
Sclerosing Epithelioid Fibrosarcoma	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	MUC4
Secondary Adrenal Insufficiency	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	CTNNB1
Epithelioid hemangioendothelioma, malignant	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	MYC
Burkitt-like lymphoma	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	MYC
Glycogen storage disease type Ia	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	CTNNB1
Precursor B-lymphoblastic lymphoma/leukemia	1/9	0.00224816055240216	0.00726032671546314	0	0	624.59375	3808.549663430724	MYC
Infection caused by Helicobacter pylori	2/308	0.0022924544828576785	0.007378104359504406	0	0	42.89542483660131	260.72406331107476	CDH1;RAC1
Fibroid Tumor	2/310	0.002321904184869269	0.00744746818480177	0	0	42.612554112554115	258.46080765030825	MYC;CTNNB1
Hepatitis	2/317	0.0024264097918535394	0.007722421363729605	0	0	41.65079365079365	250.793696719293	MYC;CTNNB1
Chorea Acanthocytosis Syndrome	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	RAC1
Subacute progressive viral hepatitis	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CTNNB1
Post-transplant lymphoproliferative disorder, polymorphic	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	MYC
NUT midline carcinoma	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	MYC
stage, endometrial cancer	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CTNNB1
Congenital euryblepharon	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CDH1
Papilledema	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CTNNB1
Pilomatrixoma	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CTNNB1
Kabuki syndrome eyelids	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	CDH1
Low-grade fibromyxoid sarcoma	1/10	0.0024977078641967437	0.007722421363729605	0	0	555.1666666666666	3326.7706415121643	MUC4
Barrett Esophagus	2/323	0.002517755755607112	0.007739113484078706	0	0	40.85981308411215	244.52094843877143	MYC;MUC4
Lymphoma	3/1307	0.0025195205086025055	0.007739113484078706	0	0	21.500383435582823	128.6515577618238	CDH1;MYC;RAC1
T-Cell Lymphoma	2/324	0.002533138671138792	0.007755681061311302	0	0	40.73084886128365	243.50107748963148	MYC;CTNNB1
Liver neoplasms	3/1321	0.0025985573555098933	0.007930225198206567	0	0	21.25606980273141	126.53310790301806	MYC;CTNNB1;MUC4
Malignant mesothelioma	2/335	0.0027053356110775073	0.008229456391116418	0	0	39.36336336336336	232.73703937969796	CDH1;CTNNB1
extranodal lymphoma	1/11	0.002747205358336921	0.008250365136661518	0	0	499.625	2946.3741195064317	MYC
Chromosome Breaks	1/11	0.002747205358336921	0.008250365136661518	0	0	499.625	2946.3741195064317	MYC
Synovial sarcoma, biphasic	1/11	0.002747205358336921	0.008250365136661518	0	0	499.625	2946.3741195064317	MUC4
Pulmonary Blastoma	1/11	0.002747205358336921	0.008250365136661518	0	0	499.625	2946.3741195064317	CTNNB1
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	2/349	0.0029323881410578	0.008778546085769858	0	0	37.74831892411143	220.145860202533	MYC;CTNNB1
Ewings sarcoma	2/352	0.0029821889550152502	0.008858444536644862	0	0	37.41904761904762	217.59541772516445	MYC;RAC1
Lymphoma, Lymphocytic, Intermediate	1/12	0.002996653029893649	0.008858444536644862	0	0	454.1818181818182	2638.914119276588	CTNNB1
Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type	1/12	0.002996653029893649	0.008858444536644862	0	0	454.1818181818182	2638.914119276588	CDH1
OROFACIAL CLEFT 1	1/12	0.002996653029893649	0.008858444536644862	0	0	454.1818181818182	2638.914119276588	CDH1
Adenocarcinoma of pancreas	2/354	0.0030156138904512977	0.008886637183423668	0	0	37.202651515151516	215.92239836302443	CTNNB1;MUC4
Leukemia, T-Cell	2/364	0.0031854270152703004	0.00919227019582482	0	0	36.156537753222835	207.87004340270394	MYC;RAC1
Epithelioid hemangioendothelioma	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
Malignant Mixed Mesodermal (Mullerian) Tumor	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
B Lymphoblastic Lymphoma	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
Micropapillary carcinoma	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
cancer angiogenesis	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	RAC1
Cells in urine	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
Hamartomatous polyp	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	CTNNB1
Polycystic kidney disease, type 2	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
Abnormality of the abdominal wall	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	CTNNB1
Peritoneal Neoplasms	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	CTNNB1
Infantile malignant osteopetrosis	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	RAC1
Primary Cutaneous Follicle Center Lymphoma	1/13	0.003246050875089783	0.00919227019582482	0	0	416.3125	2385.6022367218384	MYC
Nephroblastoma	2/370	0.003289461556644305	0.009287312119507724	0	0	35.55615942028985	203.27567944939662	CDH1;CTNNB1
Familial Exudative Vitreoretinopathy	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Mesenchymal Chondrosarcoma	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	MYC
Fibromatosis	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Micronodular cirrhosis	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Nephrogenic rest	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
hemangiopericytoma	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Thyroid Lymphoma	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	MYC
Trisomy 11	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	MYC
Uterine Polyp	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Peritoneal Surface Malignancy	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	CTNNB1
Adams Oliver syndrome	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	RAC1
Deficiency of mevalonate kinase	1/14	0.0034953988931204698	0.009517903736437143	0	0	384.2692307692308	2173.5450385769154	RAC1
Age related macular degeneration	2/382	0.0035023463377981856	0.009517903736437143	0	0	34.41228070175438	194.57812110252155	CTNNB1;RAC1
Mesothelioma	2/383	0.003520375986679735	0.009539409642066062	0	0	34.32020997375328	193.88130051799234	CDH1;CTNNB1
Carcinoma breast stage IV	2/392	0.003684640655715828	0.009919239747622233	0	0	33.51282051282051	187.79184696080642	CDH1;MYC
Adenocarcinoma, metastatic	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	MYC
Salivary gland carcinoma	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	CDH1
Helicobacter Infections	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	CDH1
Nodular melanoma	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	MYC
Peg-shaped teeth	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	CDH1
Plasmacytosis	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	MYC
Pointed tooth	1/15	0.00374469708393798	0.009919239747622233	0	0	356.80357142857144	1993.609466758919	CDH1
Diabetes Mellitus	3/1507	0.0038028875583312224	0.010045162373967347	0	0	18.44182180851064	102.75773184550447	MYC;CTNNB1;RAC1
Carcinoma, Transitional Cell	2/399	0.003814883766557547	0.010048702211909961	0	0	32.91015952980688	183.27158005170273	CDH1;MYC
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	2/408	0.003985521477648071	0.01029041136088051	0	0	32.16584564860427	177.71909934145316	MYC;RAC1
Blastoma	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	CTNNB1
Focal Nodular Hyperplasia	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	CTNNB1
Focal nodular hyperplasia of liver	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	CTNNB1
Nephrosis, congenital	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	RAC1
Osteoblastoma	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	CTNNB1
Ovarian Granulosa Cell Tumor	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	CTNNB1
premalignant lesion	1/16	0.003993945448655638	0.01029041136088051	0	0	333.0	1839.1509089009865	MUC4
Atypical Endometrial Hyperplasia	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	CTNNB1
Biliary Tract Neoplasm	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	MUC4
Multiple congenital anomalies	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	CTNNB1
Liposarcoma, Pleomorphic	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	MYC
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	CTNNB1
Hepatic necrosis	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	CTNNB1
Occlusive vascular disease	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	MYC
Coronary Restenosis	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	MYC
Portal vein thrombosis	1/17	0.004243143988996933	0.010670092750997623	0	0	312.171875	1705.2235013634931	CTNNB1
Inflammation	2/429	0.0043975438424966335	0.010862133394909153	0	0	30.551131928181107	165.79210600233102	CDH1;CTNNB1
Pulmonary Fibrosis	2/432	0.004457983484974999	0.010862133394909153	0	0	30.333333333333332	164.1961153744115	CDH1;RAC1
Malignant neoplasm of other specified sites of female breast	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	MYC
Malignant neoplasm tonsil	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	CDH1
Benign neoplasm of stomach	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	CDH1
Decreased visual acuity, slowly progressive	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	CTNNB1
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	RAC1
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	RAC1
Carcinoma in situ of stomach	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	CDH1
Smoldering myeloma	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	MYC
Neoplasm of uncertain or unknown behavior of stomach	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	CDH1
Pancreatic carcinoma resectable	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	MUC4
Cryptosporidiosis	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	RAC1
Adult Burkitt Lymphoma	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	MYC
Laryngitis	1/18	0.0044922927083929694	0.010862133394909153	0	0	293.79411764705884	1588.072397289777	MUC4
Anaplastic Large Cell Lymphoma, ALK-Positive	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	MYC
Carcinoma in situ of endometrium	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	CTNNB1
Carcinoma of extrahepatic bile duct	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	MUC4
Slow decrease in visual acuity	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	CTNNB1
Abnormality of the musculature	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	CTNNB1
Inflammatory disease of mucous membrane	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	MUC4
Enchondroma	1/19	0.00474139160939957	0.011262297953813085	0	0	277.4583333333333	1484.7973498875915	MYC
Central neuroblastoma	3/1655	0.004979018503358209	0.011562618123544015	0	0	16.655266343825666	88.31492444916775	MYC;CTNNB1;RAC1
Adenocarcinoma of lung, stage I	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	MYC
Enteropathy-Associated T-Cell Lymphoma	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	MYC
Solitary fibrous tumor	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	CTNNB1
Squamous cell carcinoma of penis	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	MYC
High Grade Intraepithelial Neoplasia	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	MYC
Chronic ulcerative colitis	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	CTNNB1
Tonsillar Carcinoma	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	CDH1
Adenosis of Breast	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	MYC
Arteriosclerosis Obliterans	1/20	0.00499044069595166	0.011562618123544015	0	0	262.8421052631579	1393.123889480945	RAC1
Anaplastic large cell lymphoma, ALK negative	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	MYC
Fibrolamellar Hepatocellular Carcinoma	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	CDH1
Neoplasms, Neuroepithelial	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	CDH1
Neoplasms, Radiation-Induced	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	MYC
Heparin-induced thrombocytopenia	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	MYC
Otitis Media with Effusion	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	MUC4
Intestinal Polyposis	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	CTNNB1
Pseudomyxoma Peritonei	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	CDH1
Little's Disease	1/21	0.005239439972471158	0.011876903591443033	0	0	249.6875	1311.2440590040192	CTNNB1
Neuroblastoma	3/1698	0.005359143449650232	0.01211911816071983	0	0	16.194690265486727	84.6812438153606	MYC;CTNNB1;RAC1
Mammary Neoplasms, Human	2/476	0.0053894637300426745	0.012129509063079337	0	0	27.455696202531644	143.40959585257406	CDH1;CTNNB1
Thyroid Neoplasm	2/476	0.0053894637300426745	0.012129509063079337	0	0	27.455696202531644	143.40959585257406	CDH1;CTNNB1
Breast cancer, lobular	1/22	0.005488389443320514	0.012206488785498218	0	0	237.78571428571428	1237.7032790036255	CDH1
Leukemia, T-Cell, Chronic	1/22	0.005488389443320514	0.012206488785498218	0	0	237.78571428571428	1237.7032790036255	MYC
Abnormal lactate dehydrogenase activity	1/22	0.005488389443320514	0.012206488785498218	0	0	237.78571428571428	1237.7032790036255	MYC
Adenoid cystic carcinoma of salivary gland	1/22	0.005488389443320514	0.012206488785498218	0	0	237.78571428571428	1237.7032790036255	MYC
Adrenal Cancer	1/22	0.005488389443320514	0.012206488785498218	0	0	237.78571428571428	1237.7032790036255	CTNNB1
fibroma	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	CTNNB1
Severe hereditary factor VIII deficiency disease	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	MYC
Sporadic Burkitt's lymphoma	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	MYC
Hemimegalencephaly	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	MYC
Neuroepithelioma	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	MYC
Increased gastric cancer	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	CTNNB1
Activated B-cell type diffuse large B-cell lymphoma	1/23	0.005737289113328647	0.012552815855844349	0	0	226.9659090909091	1171.3185051583378	MYC
Congenital chromosomal disease	2/497	0.005863541271073641	0.01279935050607047	0	0	26.262626262626263	134.9636769511218	CDH1;MYC
Myeloid Leukemia	2/501	0.0059559874285141185	0.012887965902518363	0	0	26.04676018704075	133.4468843383222	MYC;RAC1
Sebaceous adenoma	1/24	0.0059861389875960165	0.012887965902518363	0	0	217.08695652173913	1111.1180475941821	RAC1
Secondary hypothyroidism	1/24	0.0059861389875960165	0.012887965902518363	0	0	217.08695652173913	1111.1180475941821	CTNNB1
Gardner Syndrome	1/24	0.0059861389875960165	0.012887965902518363	0	0	217.08695652173913	1111.1180475941821	CTNNB1
Leukemia, Mast-Cell	1/24	0.0059861389875960165	0.012887965902518363	0	0	217.08695652173913	1111.1180475941821	CTNNB1
Lymphoma, Undifferentiated	1/24	0.0059861389875960165	0.012887965902518363	0	0	217.08695652173913	1111.1180475941821	MYC
Malignant neoplasm of thyroid	2/505	0.00604911805018149	0.012993891392531083	0	0	25.834327369118622	131.9576829004036	MYC;CTNNB1
Secondary malignant neoplasm of liver	2/508	0.006119414660892141	0.01311501823913929	0	0	25.677206851119895	130.8584624783484	MYC;CTNNB1
Tumor Angiogenesis	2/511	0.00619009540833149	0.013212466389789176	0	0	25.521938441388343	129.77407455876164	MYC;RAC1
Malignant lymphoma - lymphoplasmacytic	1/25	0.0062349390704731535	0.013212466389789176	0	0	208.03125	1056.2966607689368	MYC
Cervix Diseases	1/25	0.0062349390704731535	0.013212466389789176	0	0	208.03125	1056.2966607689368	MUC4
Non-infiltrating lobular carcinoma	1/25	0.0062349390704731535	0.013212466389789176	0	0	208.03125	1056.2966607689368	CDH1
Pulmonary Sclerosing Hemangioma	1/25	0.0062349390704731535	0.013212466389789176	0	0	208.03125	1056.2966607689368	CTNNB1
Malignant neoplasm of large intestine	2/516	0.006308749273268768	0.013338902611418046	0	0	25.267185473411153	127.99895882419331	CDH1;MYC
Hereditary nonpolyposis colorectal carcinoma	1/26	0.006483689369798885	0.013617191705390531	0	0	199.7	1006.1815770136444	CTNNB1
Hyperprolactinemia	1/26	0.006483689369798885	0.013617191705390531	0	0	199.7	1006.1815770136444	CTNNB1
Plasmablastic lymphoma	1/26	0.006483689369798885	0.013617191705390531	0	0	199.7	1006.1815770136444	MYC
Rheumatoid Arthritis	3/1833	0.006670236507682854	0.013953062999872362	0	0	14.889344262295081	74.59710311171173	MYC;RAC1;MUC4
Extraskeletal Myxoid Chondrosarcoma	1/27	0.006732389888591648	0.013953062999872362	0	0	192.0096153846154	960.2065018708713	MYC
Mucinous neoplasm	1/27	0.006732389888591648	0.013953062999872362	0	0	192.0096153846154	960.2065018708713	MUC4
Thymic Lymphoma	1/27	0.006732389888591648	0.013953062999872362	0	0	192.0096153846154	960.2065018708713	MYC
Cryoglobulinemia	1/27	0.006732389888591648	0.013953062999872362	0	0	192.0096153846154	960.2065018708713	MYC
Lobular carcinoma in situ of breast	1/27	0.006732389888591648	0.013953062999872362	0	0	192.0096153846154	960.2065018708713	CDH1
Retinoblastoma	2/539	0.006868238087636791	0.014203395869827837	0	0	24.156424581005588	120.31947109761705	MYC;CTNNB1
Malignant Mesothelioma of Peritoneum	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	MYC
Lymphoma, AIDS-Related	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	MYC
Lymphoma, Small Noncleaved-Cell	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	MYC
Childhood Burkitt Lymphoma	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	MYC
Hereditary non-polyposis colorectal cancer syndrome	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	CDH1
Odontogenic Tumors	1/28	0.006981040634233312	0.014242415308424478	0	0	184.88888888888889	917.8914803082985	CTNNB1
Metastatic Neoplasm	2/544	0.006992829573489431	0.014242415308424478	0	0	23.92742927429274	118.7487209601415	MYC;RAC1
Fibrosis, Liver	2/545	0.007017874476919122	0.014262619895980023	0	0	23.882136279926335	118.43855636415508	CTNNB1;RAC1
Cardiac Lymphoma	1/29	0.007229641611706164	0.01459861250500838	0	0	178.27678571428572	878.8271482248972	MYC
T-Cell Prolymphocytic Leukemia	1/29	0.007229641611706164	0.01459861250500838	0	0	178.27678571428572	878.8271482248972	MYC
Asbestosis	1/29	0.007229641611706164	0.01459861250500838	0	0	178.27678571428572	878.8271482248972	RAC1
Hematologic Neoplasms	2/557	0.007321698602148717	0.014722204253265984	0	0	23.35135135135135	114.81656135633972	CDH1;MYC
Lymphoid neoplasm	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	MYC
Carcinoma, Signet Ring Cell	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	CDH1
Bilateral Wilms Tumor	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	CTNNB1
Bone necrosis	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	CTNNB1
Optic Atrophy, Autosomal Dominant	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	CDH1
Christ-Siemens-Touraine syndrome	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	RAC1
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	MYC
Ventricular Dysfunction, Left	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	RAC1
Cornelia De Lange Syndrome	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	MYC
African Burkitt's lymphoma	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	MYC
Prostatic Hypertrophy	1/30	0.007478192828541258	0.014722204253265984	0	0	172.1206896551724	842.6622961465415	MYC
Mycoplasma-Induced Stevens-Johnson Syndrome	1/31	0.007726694289035996	0.015116748370458389	0	0	166.375	809.0939625056958	CTNNB1
Plasma Cell Neoplasm	1/31	0.007726694289035996	0.015116748370458389	0	0	166.375	809.0939625056958	MYC
Drug-Induced Stevens Johnson Syndrome	1/31	0.007726694289035996	0.015116748370458389	0	0	166.375	809.0939625056958	CTNNB1
Diffuse Large B-Cell Lymphoma	2/575	0.007788768502492042	0.015206643266770176	0	0	22.596858638743456	109.70938738293013	CDH1;MYC
Glioblastoma	3/1937	0.007806487542833631	0.015209747423330814	0	0	14.008014477766288	67.97809482511947	MYC;CTNNB1;RAC1
Gastrinoma	1/32	0.007975146000148757	0.015379473779427971	0	0	161.0	777.8594770432692	CDH1
Increased hepatocellular carcinoma risk	1/32	0.007975146000148757	0.015379473779427971	0	0	161.0	777.8594770432692	CTNNB1
Increased incidence of hepatocellular carcinoma	1/32	0.007975146000148757	0.015379473779427971	0	0	161.0	777.8594770432692	CTNNB1
Verrucous carcinoma	1/32	0.007975146000148757	0.015379473779427971	0	0	161.0	777.8594770432692	CDH1
Anhedonia	1/32	0.007975146000148757	0.015379473779427971	0	0	161.0	777.8594770432692	RAC1
Central Diabetes Insipidus	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	CTNNB1
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	CTNNB1
Trigeminal Neuralgia	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	CTNNB1
Craniopharyngioma	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	CTNNB1
Polyarteritis Nodosa	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	MYC
Primary angle-closure glaucoma	1/33	0.008223547969126478	0.015666274211891453	0	0	155.9609375	748.7300222782447	RAC1
Rhabdoid Tumor of the Kidney	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	RAC1
Richter's syndrome	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	MYC
Secondary malignant neoplasm of pancreas	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	MUC4
Cancer of Urinary Tract	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	CTNNB1
Neuroectodermal Tumors	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	MYC
Sarcoma, Spindle Cell	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	CDH1
Cleft Lip with or without Cleft Palate	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	CDH1
Angle Closure Glaucoma	1/34	0.008471900201487836	0.015882707534797275	0	0	151.22727272727272	721.5053863184621	RAC1
Congenital Abnormality	2/607	0.008652469119605053	0.015998348540115555	0	0	21.366391184573004	101.48844693331736	MYC;CTNNB1
Excessive daytime somnolence	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	CTNNB1
Split-Hand/Foot Malformation	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	RAC1
Neoplasm of uncertain or unknown behavior of ovary	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	CTNNB1
Neoplasms, Germ Cell and Embryonal	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	MYC
Hepatitis B Virus-Related Hepatocellular Carcinoma	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	CDH1
Complete trisomy 18 syndrome	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	MYC
Varicose Ulcer	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	MYC
Acinar Cell Carcinoma	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	CTNNB1
Leiomyosarcoma of uterus	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	CTNNB1
Limb defects	1/35	0.008720202703732128	0.015998348540115555	0	0	146.77205882352942	696.0096581675563	RAC1
Endometriosis of ovary	1/36	0.008968455482759895	0.01635832402368004	0	0	142.57142857142858	672.0876744444516	CDH1
Mesenchymal Cell Neoplasm	1/36	0.008968455482759895	0.01635832402368004	0	0	142.57142857142858	672.0876744444516	CTNNB1
Oestrogen deficiency	1/36	0.008968455482759895	0.01635832402368004	0	0	142.57142857142858	672.0876744444516	MYC
Adenoma, Basal Cell	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	CTNNB1
Adenoma, Monomorphic	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	CTNNB1
Bone Marrow Diseases	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	MYC
Hematopoetic Myelodysplasia	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	MYC
Tubular Aggregate Myopathy	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	MYC
Immunoblastic Large-Cell Lymphoma	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	MYC
ACTH-Secreting Pituitary Adenoma	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	CDH1
Aggressive Non-Hodgkin Lymphoma	1/37	0.009216658544821541	0.016554874300508025	0	0	138.60416666666666	649.6020692107373	MYC
Adenoma, Trabecular	1/38	0.009464811895936884	0.01684022192050657	0	0	134.85135135135135	628.4308110799436	CTNNB1
Mediastinal (Thymic) Large B-Cell Lymphoma	1/38	0.009464811895936884	0.01684022192050657	0	0	134.85135135135135	628.4308110799436	MYC
Milroy Disease	1/38	0.009464811895936884	0.01684022192050657	0	0	134.85135135135135	628.4308110799436	MYC
Comedone	1/38	0.009464811895936884	0.01684022192050657	0	0	134.85135135135135	628.4308110799436	MYC
Papillary adenoma	1/38	0.009464811895936884	0.01684022192050657	0	0	134.85135135135135	628.4308110799436	CTNNB1
Immunologic Deficiency Syndromes	2/641	0.00961650002192917	0.01707788986945237	0	0	20.194053208137714	93.78673451628448	MYC;RAC1
Malignant neoplasm of adrenal cortex	1/39	0.009712915544850792	0.017120148334194948	0	0	131.29605263157896	608.465136485093	CTNNB1
Subependymal Giant Cell Astrocytoma	1/39	0.009712915544850792	0.017120148334194948	0	0	131.29605263157896	608.465136485093	MYC
Adenocarcinoma of rectum	1/39	0.009712915544850792	0.017120148334194948	0	0	131.29605263157896	608.465136485093	MYC
Low Grade Lymphoma (neoplasm)	1/39	0.009712915544850792	0.017120148334194948	0	0	131.29605263157896	608.465136485093	MYC
Muscular Dystrophy, Oculopharyngeal	1/40	0.009960969495176103	0.01745946883634027	0	0	127.92307692307692	589.6078070933972	CTNNB1
Chemical Carcinogenesis	1/40	0.009960969495176103	0.01745946883634027	0	0	127.92307692307692	589.6078070933972	RAC1
Hereditary Nonpolyposis Colorectal Neoplasms	1/40	0.009960969495176103	0.01745946883634027	0	0	127.92307692307692	589.6078070933972	CDH1
Micronychia (disorder)	1/41	0.010208973756811941	0.017762107477257677	0	0	124.71875	571.7716333774792	CDH1
Intestinal Polyps	1/41	0.010208973756811941	0.017762107477257677	0	0	124.71875	571.7716333774792	CTNNB1
Laryngeal neoplasm	1/41	0.010208973756811941	0.017762107477257677	0	0	124.71875	571.7716333774792	CDH1
Prolymphocytic Leukemia	1/41	0.010208973756811941	0.017762107477257677	0	0	124.71875	571.7716333774792	MYC
Clear Cell Sarcoma of Soft Tissue	1/42	0.01045692833454581	0.018060226042997618	0	0	121.67073170731707	554.8782187239776	MYC
Vascular Neoplasms	1/42	0.01045692833454581	0.018060226042997618	0	0	121.67073170731707	554.8782187239776	MYC
Isochromosomes	1/42	0.01045692833454581	0.018060226042997618	0	0	121.67073170731707	554.8782187239776	MYC
Arrhythmogenic Right Ventricular Dysplasia	1/42	0.01045692833454581	0.018060226042997618	0	0	121.67073170731707	554.8782187239776	CTNNB1
Autistic Disorder	2/677	0.01068870448146545	0.018387354721813656	0	0	19.081481481481482	86.60259649409569	CTNNB1;RAC1
Carcinoma of urinary bladder, superficial	1/43	0.010704833236771683	0.018387354721813656	0	0	118.76785714285714	538.8568862241955	CDH1
intracranial glioma	1/43	0.010704833236771683	0.018387354721813656	0	0	118.76785714285714	538.8568862241955	CDH1
Secondary malignant neoplasm of lung	2/683	0.010872508494524974	0.018641410018794637	0	0	18.90748898678414	85.4905486160102	MYC;CTNNB1
Monoclonal Gammapathies	1/44	0.010952688469357683	0.018710842801819373	0	0	116.0	523.6437583425852	MYC
Chromosome Breakage	1/44	0.010952688469357683	0.018710842801819373	0	0	116.0	523.6437583425852	MYC
Adenoma, Microcystic	1/45	0.011200494038323646	0.01899652136355971	0	0	113.35795454545455	509.18096448649436	CTNNB1
Atypical Teratoid Rhabdoid Tumor	1/45	0.011200494038323646	0.01899652136355971	0	0	113.35795454545455	509.18096448649436	MYC
Mammary adenocarcinoma	1/45	0.011200494038323646	0.01899652136355971	0	0	113.35795454545455	509.18096448649436	MUC4
Leukemia, Plasma Cell	1/45	0.011200494038323646	0.01899652136355971	0	0	113.35795454545455	509.18096448649436	MYC
Malignant neoplasm of male breast	1/46	0.011448249952996578	0.019243671489618135	0	0	110.83333333333333	495.41595635428416	MYC
Basal Cell Nevus Syndrome	1/46	0.011448249952996578	0.019243671489618135	0	0	110.83333333333333	495.41595635428416	MYC
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.011448249952996578	0.019243671489618135	0	0	110.83333333333333	495.41595635428416	MYC
Adult Diffuse Large B-Cell Lymphoma	1/46	0.011448249952996578	0.019243671489618135	0	0	110.83333333333333	495.41595635428416	MYC
Early gastric cancer	1/46	0.011448249952996578	0.019243671489618135	0	0	110.83333333333333	495.41595635428416	MYC
Carcinoma, Pancreatic Ductal	1/47	0.011695956218302144	0.019486372285969826	0	0	108.41847826086956	482.3009144981259	MUC4
Carcinoma in situ of uterine cervix	1/47	0.011695956218302144	0.019486372285969826	0	0	108.41847826086956	482.3009144981259	CDH1
Muscular Atrophy	1/47	0.011695956218302144	0.019486372285969826	0	0	108.41847826086956	482.3009144981259	CTNNB1
Colonic Polyps	1/47	0.011695956218302144	0.019486372285969826	0	0	108.41847826086956	482.3009144981259	CTNNB1
Hyperparathyroidism	1/47	0.011695956218302144	0.019486372285969826	0	0	108.41847826086956	482.3009144981259	CTNNB1
Corneal Neovascularization	1/48	0.011943612841183377	0.019794071896723945	0	0	106.1063829787234	469.7922320558719	MUC4
keratoacanthoma	1/48	0.011943612841183377	0.019794071896723945	0	0	106.1063829787234	469.7922320558719	CTNNB1
Embryonal Neoplasm	1/48	0.011943612841183377	0.019794071896723945	0	0	106.1063829787234	469.7922320558719	MYC
Female Breast Carcinoma	1/49	0.012191219830698688	0.020098462063546964	0	0	103.890625	457.8500644039375	MYC
Nervous System Neoplasms	1/49	0.012191219830698688	0.020098462063546964	0	0	103.890625	457.8500644039375	MYC
Abnormality of vision	1/49	0.012191219830698688	0.020098462063546964	0	0	103.890625	457.8500644039375	CDH1
B-Cell Lymphomas	2/730	0.012362253079628995	0.020258664754377376	0	0	17.643772893772894	77.51099200837999	CDH1;MYC
Lymphedema	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	MYC
Cervical Squamous Intraepithelial Neoplasia	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	MYC
Hepatitis D Infection	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	MYC
stage, prostate cancer	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	MYC
Turcot syndrome (disorder)	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	CTNNB1
Li-Fraumeni Syndrome	1/50	0.012438777192772534	0.020258664754377376	0	0	101.76530612244898	446.4379351400606	CDH1
Malignant neoplasm of female breast	1/51	0.012686284934182437	0.0205200114801613	0	0	99.725	435.52239025630115	MYC
Breast Diseases	1/51	0.012686284934182437	0.0205200114801613	0	0	99.725	435.52239025630115	MYC
NONAKA MYOPATHY	1/51	0.012686284934182437	0.0205200114801613	0	0	99.725	435.52239025630115	RAC1
Adult Lymphoma	1/51	0.012686284934182437	0.0205200114801613	0	0	99.725	435.52239025630115	MYC
Neurodegenerative Disorders	2/745	0.012856208957295105	0.020759255217002198	0	0	17.27411395244504	75.21025527056749	CTNNB1;RAC1
Invasive Lobular Breast Carcinoma	1/52	0.012933743059820464	0.02084875163318068	0	0	97.76470588235294	425.072693906196	CDH1
Hyperparathyroidism, Primary	1/53	0.013181151581290242	0.021067501595180844	0	0	95.8798076923077	415.0605599326822	CTNNB1
Leukemia, Lymphocytic, Acute, L2	1/53	0.013181151581290242	0.021067501595180844	0	0	95.8798076923077	415.0605599326822	MYC
granulosa cell tumor	1/53	0.013181151581290242	0.021067501595180844	0	0	95.8798076923077	415.0605599326822	CTNNB1
Childhood Lymphoma	1/53	0.013181151581290242	0.021067501595180844	0	0	95.8798076923077	415.0605599326822	MYC
Stevens-Johnson Syndrome	1/53	0.013181151581290242	0.021067501595180844	0	0	95.8798076923077	415.0605599326822	CTNNB1
Malignant neoplasm of nasopharynx	1/54	0.013428510503704935	0.021390346967894856	0	0	94.06603773584905	405.45991459490074	CDH1
Hepatocellular Adenoma	1/54	0.013428510503704935	0.021390346967894856	0	0	94.06603773584905	405.45991459490074	CTNNB1
Lymphoma, Diffuse	1/55	0.013675819832555556	0.02167445059176452	0	0	92.31944444444444	396.2466860772184	MYC
Osteoporosis, Postmenopausal	1/55	0.013675819832555556	0.02167445059176452	0	0	92.31944444444444	396.2466860772184	RAC1
Primary central nervous system lymphoma	1/55	0.013675819832555556	0.02167445059176452	0	0	92.31944444444444	396.2466860772184	MYC
HER2 gene amplification	1/56	0.013923079575958213	0.02199240207726733	0	0	90.63636363636364	387.3986174905012	CTNNB1
Adult Cholangiocarcinoma	1/56	0.013923079575958213	0.02199240207726733	0	0	90.63636363636364	387.3986174905012	MUC4
Nasopharyngeal carcinoma	2/782	0.014112492776971708	0.022160171189280313	0	0	16.423076923076923	69.97371945328686	CDH1;MYC
Hepatitis C	2/783	0.014147189658220344	0.022160171189280313	0	0	16.40119504908237	69.84021308460996	MYC;CTNNB1
Peutz-Jeghers Syndrome	1/57	0.014170289742456021	0.022160171189280313	0	0	89.01339285714286	378.8951003721936	CTNNB1
Pneumocystis jiroveci pneumonia	1/57	0.014170289742456021	0.022160171189280313	0	0	89.01339285714286	378.8951003721936	CTNNB1
Ameloblastoma	1/57	0.014170289742456021	0.022160171189280313	0	0	89.01339285714286	378.8951003721936	CTNNB1
Ectodermal Dysplasia	1/57	0.014170289742456021	0.022160171189280313	0	0	89.01339285714286	378.8951003721936	RAC1
Carcinoma, Lobular	1/58	0.014417450339007641	0.02243507536251519	0	0	87.44736842105263	370.71702609175657	CDH1
Mycoplasma Infections	1/58	0.014417450339007641	0.02243507536251519	0	0	87.44736842105263	370.71702609175657	CDH1
Oncocytic Neoplasm	1/58	0.014417450339007641	0.02243507536251519	0	0	87.44736842105263	370.71702609175657	CDH1
Fibromatosis, Aggressive	1/59	0.014664561368472842	0.02274454172774653	0	0	85.9353448275862	362.8466529663449	CTNNB1
Squamous cell carcinoma of mouth	1/59	0.014664561368472842	0.02274454172774653	0	0	85.9353448275862	362.8466529663449	MYC
Cerebral calcification	1/60	0.014911622845291095	0.02308975425797948	0	0	84.47457627118644	355.26748708331087	CTNNB1
Cancer of Nasopharynx	1/62	0.015405597156586476	0.02366038781540887	0	0	81.69672131147541	340.92241011491575	CDH1
Nijmegen Breakage Syndrome	1/62	0.015405597156586476	0.02366038781540887	0	0	81.69672131147541	340.92241011491575	MYC
Pemphigus Vulgaris	1/62	0.015405597156586476	0.02366038781540887	0	0	81.69672131147541	340.92241011491575	CDH1
Phyllodes Tumor	1/62	0.015405597156586476	0.02366038781540887	0	0	81.69672131147541	340.92241011491575	MYC
Precursor cell lymphoblastic lymphoma	1/62	0.015405597156586476	0.02366038781540887	0	0	81.69672131147541	340.92241011491575	MYC
Fibroadenoma	1/63	0.01565251000400841	0.023922717882949644	0	0	80.375	334.1288407937727	MYC
Lichen Planus, Oral	1/63	0.01565251000400841	0.023922717882949644	0	0	80.375	334.1288407937727	MYC
Kidney Calculi	1/63	0.01565251000400841	0.023922717882949644	0	0	80.375	334.1288407937727	CDH1
Adenocarcinoma, Endometrioid	1/64	0.015899373323518626	0.024182433942061394	0	0	79.0952380952381	327.57099739379095	CTNNB1
Osteopetrosis	1/64	0.015899373323518626	0.024182433942061394	0	0	79.0952380952381	327.57099739379095	MYC
Cytogenetically normal acute myeloid leukemia	1/64	0.015899373323518626	0.024182433942061394	0	0	79.0952380952381	327.57099739379095	CDH1
Lymphocytosis	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	MYC
Mammary Ductal Carcinoma	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	CDH1
Melanocytic nevus of skin	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	MYC
Multiple, subcutaneous nodules	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	CTNNB1
Subcutaneous nodule	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	CTNNB1
Adult Liver Carcinoma	1/65	0.01614618712589544	0.024322451213609264	0	0	77.85546875	321.23721893054926	MYC
Shigella Infections	1/66	0.016392951412672795	0.024537386003413406	0	0	76.65384615384616	315.11658961920176	RAC1
Giant Cell Tumor of Bone	1/66	0.016392951412672795	0.024537386003413406	0	0	76.65384615384616	315.11658961920176	MYC
Cleft palate with cleft lip	1/66	0.016392951412672795	0.024537386003413406	0	0	76.65384615384616	315.11658961920176	CDH1
stage, non-small cell lung cancer	1/66	0.016392951412672795	0.024537386003413406	0	0	76.65384615384616	315.11658961920176	MYC
Oxyphilic Adenoma	1/67	0.016639666196472655	0.02482785636593942	0	0	75.48863636363636	309.1988806923386	CDH1
Toxic Epidermal Necrolysis	1/67	0.016639666196472655	0.02482785636593942	0	0	75.48863636363636	309.1988806923386	CTNNB1
Glioblastoma Multiforme	2/854	0.01670942424640521	0.024892554604044412	0	0	14.97887323943662	61.29028978210645	MYC;CTNNB1
Carcinoma, Large Cell	1/68	0.016886331477543003	0.025116420478427527	0	0	74.35820895522389	303.4744977483959	MUC4
Malignant neoplasm of salivary gland	1/69	0.017132947269309973	0.025403096344275636	0	0	73.26102941176471	297.9344326341269	CDH1
Chronic otitis media	1/69	0.017132947269309973	0.025403096344275636	0	0	73.26102941176471	297.9344326341269	MUC4
Benign Neoplasm	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	MYC
Chromosome 8, trisomy	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	MYC
Glaucoma, Open-Angle	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	CDH1
Neurofibromatosis 2	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	RAC1
Stromal Neoplasm	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	CTNNB1
Hereditary pancreatitis	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	CDH1
Ovarian adenocarcinoma	1/70	0.017379513575201528	0.025488151324129144	0	0	72.19565217391305	292.57021981956115	CDH1
Rhabdoid Tumor	1/71	0.017626030405779067	0.02572963881215118	0	0	71.16071428571429	287.37389642812474	MYC
Leukemia, Myeloid, Chronic-Phase	1/71	0.017626030405779067	0.02572963881215118	0	0	71.16071428571429	287.37389642812474	MYC
Pterygium	1/71	0.017626030405779067	0.02572963881215118	0	0	71.16071428571429	287.37389642812474	MYC
Benign melanocytic nevus	1/72	0.017872497764870265	0.025968821867908568	0	0	70.15492957746478	282.3379658506009	MYC
Hyperuricemia	1/72	0.017872497764870265	0.025968821867908568	0	0	70.15492957746478	282.3379658506009	MYC
Rectal Neoplasms	1/72	0.017872497764870265	0.025968821867908568	0	0	70.15492957746478	282.3379658506009	CDH1
Failure to Thrive	1/73	0.018118915662048707	0.026245986896024472	0	0	69.17708333333333	277.45536435713205	MYC
Syndactyly of fingers	1/73	0.018118915662048707	0.026245986896024472	0	0	69.17708333333333	277.45536435713205	CDH1
DiGeorge Syndrome	1/74	0.01836528410293502	0.02656205967648424	0	0	68.22602739726027	272.71943060410257	CTNNB1
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	1/75	0.018611603098580447	0.02683599651676049	0	0	67.30067567567568	268.1238775998327	MYC
Central Nervous System Neoplasms	1/75	0.018611603098580447	0.02683599651676049	0	0	67.30067567567568	268.1238775998327	MYC
Acute lymphocytic leukemia	2/907	0.018747233898554965	0.026990292467690583	0	0	14.062615101289135	55.92292892079522	MYC;CTNNB1
Granulomatosis with polyangiitis	1/76	0.01885787265075893	0.02702579621529737	0	0	66.4	263.6627670535498	CTNNB1
Acromegaly	1/76	0.01885787265075893	0.02702579621529737	0	0	66.4	263.6627670535498	MYC
Early-Stage Breast Carcinoma	1/76	0.01885787265075893	0.02702579621529737	0	0	66.4	263.6627670535498	MYC
Inflammatory Bowel Diseases	2/911	0.018905309032249868	0.027052665276800645	0	0	13.997799779977997	55.5476437719796	RAC1;MUC4
Neoplastic Syndromes, Hereditary	1/77	0.01910409277212023	0.027172186250542046	0	0	65.52302631578948	259.33048567400635	CDH1
High-Grade Prostatic Intraepithelial Neoplasia	1/77	0.01910409277212023	0.027172186250542046	0	0	65.52302631578948	259.33048567400635	MYC
Parathyroid Adenoma	1/77	0.01910409277212023	0.027172186250542046	0	0	65.52302631578948	259.33048567400635	CTNNB1
aggressive cancer	1/77	0.01910409277212023	0.027172186250542046	0	0	65.52302631578948	259.33048567400635	MYC
Marinesco-Sjogren syndrome	1/78	0.01935026346677325	0.027398346019770533	0	0	64.66883116883118	255.1217234964787	CTNNB1
Giant Cell Glioblastoma	1/78	0.01935026346677325	0.027398346019770533	0	0	64.66883116883118	255.1217234964787	MYC
Multiple Sclerosis, Relapsing-Remitting	1/78	0.01935026346677325	0.027398346019770533	0	0	64.66883116883118	255.1217234964787	MYC
Extrahepatic Cholangiocarcinoma	1/80	0.01984245660574517	0.028011132603619305	0	0	63.0253164556962	247.054914696706	CDH1
Bloom Syndrome	1/80	0.01984245660574517	0.028011132603619305	0	0	63.0253164556962	247.054914696706	MYC
Neoplasms, Experimental	1/81	0.020088479062587667	0.028273784710477867	0	0	62.234375	243.18759198592142	CDH1
Vascular lesions	1/81	0.020088479062587667	0.028273784710477867	0	0	62.234375	243.18759198592142	MYC
Lymphoma, Large-Cell, Follicular	1/83	0.02058037579882521	0.028879902348649067	0	0	60.71036585365854	235.76368433833323	MYC
Paraganglioma	1/83	0.02058037579882521	0.028879902348649067	0	0	60.71036585365854	235.76368433833323	MYC
Syndactyly	1/85	0.021072075004587548	0.029482146482679612	0	0	59.25892857142857	228.72800210045258	RAC1
Hurthle Cell Tumor	1/85	0.021072075004587548	0.029482146482679612	0	0	59.25892857142857	228.72800210045258	CDH1
Cystadenocarcinoma, Serous	1/86	0.0213178505521487	0.02969384500838438	0	0	58.55882352941177	225.34667975778618	MYC
Headache	1/86	0.0213178505521487	0.02969384500838438	0	0	58.55882352941177	225.34667975778618	CTNNB1
Curvature of digit	1/86	0.0213178505521487	0.02969384500838438	0	0	58.55882352941177	225.34667975778618	CDH1
Nevus	1/87	0.021563576738673543	0.0299476478123257	0	0	57.875	222.05188597816456	MYC
Actinic keratosis	1/87	0.021563576738673543	0.0299476478123257	0	0	57.875	222.05188597816456	MYC
Retroviridae Infections	1/88	0.02180925357404456	0.030244303118123556	0	0	57.206896551724135	218.84045903047985	MYC
Cerebral Palsy	1/89	0.02205488106340276	0.030450589813746414	0	0	56.55397727272727	215.70938687184352	CTNNB1
Nasopharyngeal Neoplasms	1/89	0.02205488106340276	0.030450589813746414	0	0	56.55397727272727	215.70938687184352	CDH1
Congenital clinodactyly	1/89	0.02205488106340276	0.030450589813746414	0	0	56.55397727272727	215.70938687184352	CDH1
Skin carcinoma	1/90	0.02230045921440739	0.030744638946178612	0	0	55.91573033707865	212.65579845592376	CTNNB1
Meningitis	1/91	0.022545988033330695	0.031037761628366196	0	0	55.291666666666664	209.67695566371845	RAC1
Thyroid associated opthalmopathies	1/92	0.022791467529210928	0.031284357903996945	0	0	54.68131868131868	206.77024575968775	MYC
Adrenal Cortical Adenoma	1/92	0.022791467529210928	0.031284357903996945	0	0	54.68131868131868	206.77024575968775	CTNNB1
Speech Disorders	1/93	0.023036897706439092	0.03157528275751754	0	0	54.08423913043478	203.9331743799736	CTNNB1
Rotting teeth	1/95	0.02352761014601	0.03220106874845781	0	0	52.9281914893617	198.45852252396736	CDH1
Retinal Detachment	1/96	0.02377289241868387	0.03239571900407354	0	0	52.36842105263158	195.81648814874995	CTNNB1
Steroid Sulfatase Deficiency Disease	1/96	0.02377289241868387	0.03239571900407354	0	0	52.36842105263158	195.81648814874995	MYC
Werner Syndrome	1/96	0.02377289241868387	0.03239571900407354	0	0	52.36842105263158	195.81648814874995	MYC
Neoplasms, Intracranial	1/97	0.024018125407556302	0.03263557962438846	0	0	51.8203125	193.23517335892032	MYC
Ductal Breast Carcinoma	1/97	0.024018125407556302	0.03263557962438846	0	0	51.8203125	193.23517335892032	MUC4
Nephrolithiasis	1/99	0.024508443549026968	0.03325390254206105	0	0	50.75765306122449	188.24681569293375	CDH1
Myalgia	1/100	0.024753528718293626	0.033490068265926674	0	0	50.24242424242424	185.83603697375267	CTNNB1
Childhood Neuroblastoma	1/100	0.024753528718293626	0.033490068265926674	0	0	50.24242424242424	185.83603697375267	MYC
Otitis Media	1/101	0.024998564628756072	0.03372481608714875	0	0	49.7375	183.4784976020638	MUC4
Xeroderma Pigmentosum	1/101	0.024998564628756072	0.03372481608714875	0	0	49.7375	183.4784976020638	MYC
Heart Decompensation	1/102	0.02524355128901587	0.03390978470874924	0	0	49.242574257425744	181.17251842856115	RAC1
Inflammatory Breast Carcinoma	1/102	0.02524355128901587	0.03390978470874924	0	0	49.242574257425744	181.17251842856115	MYC
Intervertebral Disc Degeneration	1/102	0.02524355128901587	0.03390978470874924	0	0	49.242574257425744	181.17251842856115	CTNNB1
Ichthyosis, X-Linked	1/103	0.025488488708855967	0.03419010647574847	0	0	48.75735294117647	178.91648898231432	MYC
Carcinoid tumor no ICD-O subtype	1/104	0.025733376891533367	0.03442067292016449	0	0	48.28155339805825	176.70886404310096	MYC
Acute pancreatitis	1/104	0.025733376891533367	0.03442067292016449	0	0	48.28155339805825	176.70886404310096	RAC1
Mixed Salivary Gland Tumor	1/105	0.025978215844994757	0.034698948359532654	0	0	47.81490384615385	174.54816038097263	CTNNB1
Heart Failure, Right-Sided	1/106	0.02622300558108204	0.034976370951853415	0	0	47.357142857142854	172.43295370979877	RAC1
Red cell distribution width determination	1/108	0.02671243741313172	0.03537897258508878	0	0	46.467289719626166	168.33361194919559	RAC1
Malabsorption	1/108	0.02671243741313172	0.03537897258508878	0	0	46.467289719626166	168.33361194919559	CTNNB1
Myocardial Failure	1/108	0.02671243741313172	0.03537897258508878	0	0	46.467289719626166	168.33361194919559	RAC1
Waldenstrom Macroglobulinemia	1/108	0.02671243741313172	0.03537897258508878	0	0	46.467289719626166	168.33361194919559	MYC
RDW - Red blood cell distribution width result	1/108	0.02671243741313172	0.03537897258508878	0	0	46.467289719626166	168.33361194919559	RAC1
Abortion, Tubal	1/110	0.027201672447497008	0.03592601837253456	0	0	45.61009174311926	164.4005184703249	MUC4
Luminal A Breast Carcinoma	1/110	0.027201672447497008	0.03592601837253456	0	0	45.61009174311926	164.4005184703249	MYC
Plasmacytoma	1/111	0.027446216189273964	0.036198296316762725	0	0	45.19318181818182	162.4933038284392	MYC
Merkel cell carcinoma	1/112	0.02769071075296755	0.03636816189421783	0	0	44.78378378378378	160.62412864511748	MYC
Glomerulosclerosis (disorder)	1/112	0.02769071075296755	0.03636816189421783	0	0	44.78378378378378	160.62412864511748	RAC1
Cleft Palate	1/112	0.02769071075296755	0.03636816189421783	0	0	44.78378378378378	160.62412864511748	MYC
Adenocarcinoma, Clear Cell	1/113	0.027935156143683967	0.03663818114533238	0	0	44.38169642857143	158.79190942444083	CTNNB1
Pancreatic intraepithelial neoplasia	1/115	0.028423899449720333	0.03722741275150871	0	0	43.598684210526315	155.23420325807967	MUC4
Atherosclerosis	2/1134	0.02863729772551249	0.037339931114579	0	0	11.108951707891638	39.47060859256003	CDH1;MYC
Acute Myeloid Leukemia, M1	1/116	0.028668197377471047	0.037339931114579	0	0	43.21739130434783	153.50674237731195	MYC
Familial (FPAH)	1/116	0.028668197377471047	0.037339931114579	0	0	43.21739130434783	153.50674237731195	CDH1
Primary microcephaly	1/116	0.028668197377471047	0.037339931114579	0	0	43.21739130434783	153.50674237731195	CTNNB1
Hypogonadism, Isolated Hypogonadotropic	1/117	0.02891244616579494	0.037502664008727135	0	0	42.8426724137931	151.81228623104212	CTNNB1
Leukemia, B-Cell	1/117	0.02891244616579494	0.037502664008727135	0	0	42.8426724137931	151.81228623104212	MYC
Teratoma	1/117	0.02891244616579494	0.037502664008727135	0	0	42.8426724137931	151.81228623104212	MYC
Von Hippel-Lindau Syndrome	1/119	0.02940079634800306	0.03808372384088858	0	0	42.11228813559322	148.51881810168607	MYC
Mental Retardation	2/1158	0.029789174444460845	0.038504480748998815	0	0	10.864475201845444	38.173531160054246	CTNNB1;RAC1
Hypodontia	1/121	0.02988895006178911	0.038504480748998815	0	0	41.40625	145.34696936891217	CDH1
Acute Myeloid Leukemia (AML-M2)	1/121	0.02988895006178911	0.038504480748998815	0	0	41.40625	145.34696936891217	MYC
Adult Acute Lymphocytic Leukemia	1/121	0.02988895006178911	0.038504480748998815	0	0	41.40625	145.34696936891217	MYC
Hyperplasia	1/123	0.030376907361236518	0.03907970483171355	0	0	40.72336065573771	142.29037805694	CDH1
Polycystic Kidney Diseases	1/124	0.030620812373257762	0.039339817531310724	0	0	40.390243902439025	140.8034339839893	MYC
Thin upper lip vermilion	1/125	0.030864668306959317	0.039599159474098825	0	0	40.0625	139.34311073887577	CTNNB1
Nodule	1/126	0.031108475163385583	0.03974971826432602	0	0	39.74	137.90872784944867	CDH1
Hypogonadotropic hypogonadism	1/126	0.031108475163385583	0.03974971826432602	0	0	39.74	137.90872784944867	CTNNB1
Left-Sided Heart Failure	1/126	0.031108475163385583	0.03974971826432602	0	0	39.74	137.90872784944867	RAC1
Gastritis, Atrophic	1/127	0.0313522329588074	0.03995291308129106	0	0	39.42261904761905	136.49962740373687	CDH1
Childhood asthma	1/127	0.0313522329588074	0.03995291308129106	0	0	39.42261904761905	136.49962740373687	CDH1
Sarcomatoid Renal Cell Carcinoma	1/128	0.03159594168817669	0.04020914036700488	0	0	39.110236220472444	135.11517317733276	MUC4
Chronic liver disease	1/129	0.03183960137201664	0.04030166992457946	0	0	38.802734375	133.75474969906264	CTNNB1
liposarcoma	1/129	0.03183960137201664	0.04030166992457946	0	0	38.802734375	133.75474969906264	MYC
early pregnancy	1/129	0.03183960137201664	0.04030166992457946	0	0	38.802734375	133.75474969906264	RAC1
Endometrial adenocarcinoma	1/129	0.03183960137201664	0.04030166992457946	0	0	38.802734375	133.75474969906264	MUC4
Nausea and vomiting	1/132	0.03257028617210754	0.041171286676001895	0	0	37.908396946564885	129.81180382529053	CTNNB1
Skin Carcinogenesis	1/134	0.03305716425652778	0.041730797716071875	0	0	37.33458646616541	127.29290597247675	RAC1
Neurilemmoma	1/135	0.03330052977721721	0.04198181762020833	0	0	37.05410447761194	126.06480627555659	RAC1
Follicular adenoma	1/136	0.03354384630341102	0.04223210555956822	0	0	36.77777777777778	124.85694585579758	CTNNB1
Hamartoma Syndrome, Multiple	1/138	0.03403033237866217	0.04261700323117985	0	0	36.237226277372265	122.5000529863789	MUC4
Spontaneous abortion	1/138	0.03403033237866217	0.04261700323117985	0	0	36.237226277372265	122.5000529863789	MUC4
Collecting Duct Carcinoma of the Kidney	1/138	0.03403033237866217	0.04261700323117985	0	0	36.237226277372265	122.5000529863789	MUC4
Abdominal discomfort	1/138	0.03403033237866217	0.04261700323117985	0	0	36.237226277372265	122.5000529863789	CTNNB1
Gastrointestinal pain	1/140	0.03451662254205939	0.04316866718456499	0	0	35.71223021582734	120.21858976644734	CTNNB1
Diabetes	2/1268	0.035317382639058946	0.04411164480613588	0	0	9.862559241706162	32.97428341822375	MYC;CTNNB1
Mammary Carcinoma, Animal	1/145	0.035731491218360625	0.0445109593380635	0	0	34.463541666666664	114.82297002327991	CDH1
Animal Mammary Neoplasms	1/145	0.035731491218360625	0.0445109593380635	0	0	34.463541666666664	114.82297002327991	CDH1
Hematological Disease	1/147	0.03621709614688683	0.045056361037617794	0	0	33.988013698630134	112.77984284813093	CTNNB1
Chromophobe Renal Cell Carcinoma	1/149	0.036702505438878555	0.045540082406397994	0	0	33.52533783783784	110.79823292863162	MUC4
Adrenoleukodystrophy	1/149	0.036702505438878555	0.045540082406397994	0	0	33.52533783783784	110.79823292863162	CTNNB1
Pulmonary Hypertension	1/151	0.03718771913370342	0.046081496902867704	0	0	33.075	108.87551445247362	MYC
Aneurysm	1/152	0.03743025265226037	0.04632116568383402	0	0	32.854304635761586	107.93545874965702	RAC1
Familial lichen amyloidosis	1/153	0.03767273729463037	0.04643841995926332	0	0	32.63651315789474	107.0092062118616	CDH1
Sezary Syndrome	1/153	0.03767273729463037	0.04643841995926332	0	0	32.63651315789474	107.0092062118616	MYC
Abdominal Pain	1/153	0.03767273729463037	0.04643841995926332	0	0	32.63651315789474	107.0092062118616	CTNNB1
Focal glomerulosclerosis	1/155	0.03815755999212094	0.046974646308838186	0	0	32.20941558441559	105.19696189979993	RAC1
Mammary Neoplasms, Experimental	1/160	0.03936876192627337	0.04840253258992932	0	0	31.18867924528302	100.88859761506068	CDH1
Polycystic Kidney, Autosomal Dominant	1/161	0.03961085583189059	0.048636766991501074	0	0	30.9921875	100.06299005053823	MYC
Metastatic malignant neoplasm to brain	1/163	0.04009489722901885	0.04916708463844574	0	0	30.60648148148148	98.44593756514546	CDH1
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	1/166	0.04082059338391608	0.04996366201619672	0	0	30.045454545454547	96.1024470343946	CDH1
Retinal pigment epithelial abnormality	1/167	0.04106239455201745	0.04996366201619672	0	0	29.862951807228917	95.34232788913492	CTNNB1
Hereditary hemochromatosis	1/167	0.04106239455201745	0.04996366201619672	0	0	29.862951807228917	95.34232788913492	RAC1
Abnormality of retinal pigmentation	1/167	0.04106239455201745	0.04996366201619672	0	0	29.862951807228917	95.34232788913492	CTNNB1
Irritable Bowel Syndrome	1/167	0.04106239455201745	0.04996366201619672	0	0	29.862951807228917	95.34232788913492	CDH1
Progressive Neoplastic Disease	1/167	0.04106239455201745	0.04996366201619672	0	0	29.862951807228917	95.34232788913492	MYC
Breast adenocarcinoma	1/168	0.04130414695089004	0.05019305486429034	0	0	29.682634730538922	94.59239398831171	CDH1
Fibrosis	1/169	0.04154585059711727	0.05035698857722569	0	0	29.504464285714285	93.85245072850307	RAC1
Progressive cGVHD	1/169	0.04154585059711727	0.05035698857722569	0	0	29.504464285714285	93.85245072850307	MYC
Dental caries	1/170	0.04178750548595249	0.050520022658016916	0	0	29.328402366863905	93.12230835085767	CDH1
Developmental Disabilities	1/170	0.04178750548595249	0.050520022658016916	0	0	29.328402366863905	93.12230835085767	RAC1
Coinfection	1/171	0.04202911163714453	0.050747057969049034	0	0	29.154411764705884	92.40178176117583	RAC1
Multiple malignancy	1/176	0.04323641149866494	0.05213802563074301	0	0	28.314285714285713	88.93721798436884	MYC
Neutropenia	1/178	0.043718990497635515	0.05265262840264406	0	0	27.991525423728813	87.61271057875058	CTNNB1
Scleroderma	1/179	0.043960206972896584	0.052875606091124336	0	0	27.832865168539325	86.9629645143461	MYC
Gastritis	1/181	0.04444249388838659	0.05325193359180249	0	0	27.520833333333332	85.68774375294936	CDH1
Conductive hearing loss	1/181	0.04444249388838659	0.05325193359180249	0	0	27.520833333333332	85.68774375294936	CDH1
insulinoma	1/181	0.04444249388838659	0.05325193359180249	0	0	27.520833333333332	85.68774375294936	CTNNB1
Nephrotic Syndrome	1/182	0.04468356435447933	0.053472844145017774	0	0	27.367403314917127	85.06198182708867	RAC1
MIXED LINEAGE LEUKEMIA	1/185	0.045406483848298804	0.054200397808792114	0	0	26.91711956521739	83.23043531553799	MYC
Adrenocortical carcinoma	1/185	0.045406483848298804	0.054200397808792114	0	0	26.91711956521739	83.23043531553799	CTNNB1
Hashimoto Disease	1/186	0.04564735973515301	0.054419039481983934	0	0	26.77027027027027	82.63472487537138	MYC
Hypoplasia of corpus callosum	1/187	0.045888186999703665	0.0544994462729478	0	0	26.625	82.04620375518728	CTNNB1
Craniofacial Abnormalities	1/187	0.045888186999703665	0.0544994462729478	0	0	26.625	82.04620375518728	CTNNB1
Vomiting	1/187	0.045888186999703665	0.0544994462729478	0	0	26.625	82.04620375518728	CTNNB1
Malignant Peripheral Nerve Sheath Tumor	1/188	0.04612896564476939	0.05464775703896676	0	0	26.481283422459892	81.46474834004643	RAC1
Acquired Immunodeficiency Syndrome	1/188	0.04612896564476939	0.05464775703896676	0	0	26.481283422459892	81.46474834004643	MYC
Long philtrum	1/190	0.04661037711452347	0.05514878998619276	0	0	26.1984126984127	80.32255387898532	CTNNB1
Hematopoietic Neoplasms	1/192	0.0470915942002926	0.05564833750736331	0	0	25.921465968586386	79.2072064270803	MYC
Developmental delay (disorder)	1/193	0.047332129861881025	0.055862576295061084	0	0	25.78515625	78.65931930618633	CTNNB1
Mean Corpuscular Volume (result)	1/194	0.04757261695467209	0.056076222235319724	0	0	25.650259067357513	78.11781159487616	CDH1
Carcinoma, Papillary	1/196	0.0480534454514014	0.05657228347150003	0	0	25.384615384615383	77.05351349195841	CDH1
Tuberous Sclerosis	1/197	0.04829378686343229	0.056784340414235225	0	0	25.253826530612244	76.53051828362327	MYC
Aplasia Cutis Congenita	1/199	0.048774324068948355	0.05727794221297422	0	0	24.99621212121212	75.50233978585439	CTNNB1
Reticulocyte count (procedure)	1/202	0.04949476591627397	0.05805169683960989	0	0	24.619402985074625	74.00317671683035	CDH1
Left Ventricular Hypertrophy	1/203	0.04973481617713605	0.05826078466464509	0	0	24.496287128712872	73.51458406594195	MYC
Cervical Intraepithelial Neoplasia	1/205	0.050214771198610446	0.058750036278275006	0	0	24.253676470588236	72.55356464153554	MYC
Liver Dysfunction	1/207	0.050694532278435595	0.059237848746672574	0	0	24.015776699029125	71.61353837740344	RAC1
Neurodevelopmental Disorders	1/208	0.050934340109142044	0.05929763299126044	0	0	23.89855072463768	71.15119358869485	CTNNB1
Colorectal cancer metastatic	1/208	0.050934340109142044	0.05929763299126044	0	0	23.89855072463768	71.15119358869485	CDH1
Addictive Behavior	1/208	0.050934340109142044	0.05929763299126044	0	0	23.89855072463768	71.15119358869485	MYC
Smoking Behaviors	1/209	0.051174099476704094	0.05950329939153139	0	0	23.782451923076923	70.69385547952577	MUC4
Germ cell tumor	1/210	0.05141381038329779	0.05970840294513524	0	0	23.667464114832537	70.24144688058605	MYC
Growth failure	1/212	0.05189308685736502	0.06011692986055922	0	0	23.44075829383886	69.3511172071374	MYC
Congenital contractural arachnodactyly	1/212	0.05189308685736502	0.06011692986055922	0	0	23.44075829383886	69.3511172071374	CDH1
Lymphoid leukemia	1/213	0.052132652439860344	0.060320357362930434	0	0	23.329009433962263	68.91304936340102	MYC
Lymphoproliferative Disorders	1/215	0.05261163833184665	0.06072555073063818	0	0	23.108644859813083	68.05075155136298	MYC
Restenosis	1/215	0.05261163833184665	0.06072555073063818	0	0	23.108644859813083	68.05075155136298	MYC
Nasal Polyps	1/219	0.053569029227712686	0.06175500557669079	0	0	22.68004587155963	66.37959970393962	MUC4
Neoplasm, Residual	1/220	0.053808255979459825	0.06195504931456729	0	0	22.575342465753426	65.97256367609926	MYC
Neurogenic Muscular Atrophy	1/228	0.05572032903214463	0.06400032920500899	0	0	21.770925110132158	62.861591770453565	CTNNB1
Ki-1+ Anaplastic Large Cell Lymphoma	1/228	0.05572032903214463	0.06400032920500899	0	0	21.770925110132158	62.861591770453565	MYC
Anemia, Sickle Cell	1/231	0.056436559001109166	0.0647441303382554	0	0	21.483695652173914	61.757850506759766	MUC4
Chronic myeloproliferative disorder	1/233	0.056913804154295755	0.06513315208434575	0	0	21.29633620689655	61.03992861529406	RAC1
Promyelocytic leukemia	1/233	0.056913804154295755	0.06513315208434575	0	0	21.29633620689655	61.03992861529406	MYC
Uveal melanoma	1/236	0.057629309791798006	0.06587204743474609	0	0	21.02127659574468	59.98892132482973	MYC
Periodontitis	1/237	0.05786771514687046	0.06606447382990176	0	0	20.93114406779661	59.64529701584723	MUC4
Hepatitis B, Chronic	1/238	0.058106072244840566	0.06625637983903827	0	0	20.841772151898734	59.30495225973282	CDH1
Medullary carcinoma of thyroid	1/239	0.05834438110107419	0.06644776736511226	0	0	20.7531512605042	58.96784256019378	MYC
Chondrosarcoma	1/241	0.05882085411833834	0.0669096084844307	0	0	20.578125	58.30315425982284	MYC
Vitiligo	1/243	0.059297134239487945	0.06737011757570739	0	0	20.40599173553719	57.650891549950764	CDH1
Gastroesophageal reflux disease	1/246	0.06001119288942942	0.0680174938638605	0	0	20.153061224489797	56.69507925869006	MUC4
Leukopenia	1/246	0.06001119288942942	0.0680174938638605	0	0	20.153061224489797	56.69507925869006	CTNNB1
Patent ductus arteriosus	1/251	0.06120032701579098	0.06928200285220995	0	0	19.745	55.15968622140598	RAC1
Urothelial Carcinoma	1/257	0.06262569913560331	0.07081059266771454	0	0	19.2763671875	53.406708839732374	MYC
Malignant Pleural Mesothelioma	1/260	0.06333773567757368	0.0715299218490443	0	0	19.05019305019305	52.564702134668984	MYC
Hepatitis A	1/261	0.06357498501754066	0.0717119747267235	0	0	18.97596153846154	52.28893003645431	MYC
Endothelial dysfunction	1/262	0.06381218627175123	0.07189353841608292	0	0	18.902298850574713	52.01555578263835	RAC1
Malignant neoplasm of gastrointestinal tract	1/263	0.06404933946830116	0.07207461470000955	0	0	18.829198473282442	51.74454976281598	CDH1
Myeloproliferative disease	1/264	0.06428644459279281	0.07225520530512947	0	0	18.75665399239544	51.475882853730226	CTNNB1
Cerebral Ischemia	1/275	0.06689143105573456	0.07509359462566391	0	0	17.993613138686133	48.66704486227359	RAC1
Dwarfism	1/277	0.06736444101335251	0.0755346823728792	0	0	17.86141304347826	48.18362623270761	RAC1
Infant, Premature	1/278	0.06760087404978257	0.07570976749280875	0	0	17.796028880866427	47.944892991365684	MYC
Cerebral Infarction	1/283	0.06878232009688656	0.07685038844948344	0	0	17.476063829787233	46.78007694714773	RAC1
Squamous cell carcinoma of lung	1/283	0.06878232009688656	0.07685038844948344	0	0	17.476063829787233	46.78007694714773	MYC
Atrial Fibrillation	1/288	0.06996256823920939	0.07798428114606909	0	0	17.16724738675958	45.66135737933056	RAC1
Anoxia	1/288	0.06996256823920939	0.07798428114606909	0	0	17.16724738675958	45.66135737933056	MYC
Pituitary Neoplasms	1/296	0.07184847595123388	0.0799918687390951	0	0	16.694915254237287	43.960982034635435	CDH1
Kidney Failure	1/297	0.07208399913610561	0.08015944715253254	0	0	16.63766891891892	43.75579123938747	RAC1
Fibrosarcoma	1/298	0.07231947451883926	0.08032657770467069	0	0	16.58080808080808	43.55217567950979	RAC1
Pancreatitis, Chronic	1/302	0.0732608980424061	0.08127650218116347	0	0	16.357142857142858	42.75312659443924	MUC4
Malignant neoplasm of skin	1/307	0.0744366025086234	0.08248380277982592	0	0	16.08578431372549	41.78777095532115	RAC1
Celiac Disease	1/312	0.07561111344353044	0.0836869483301047	0	0	15.82315112540193	40.857781378229426	CTNNB1
Schizophrenia	2/1923	0.07589738042662575	0.08390531036612905	0	0	6.2724275550928335	16.172658534065267	CTNNB1;RAC1
Cholestasis	1/315	0.07631524749644314	0.0842684758655104	0	0	15.669585987261147	40.316003953243126	CTNNB1
Agenesis of corpus callosum	1/317	0.07678443177463125	0.08468739083447634	0	0	15.56882911392405	39.96134460516117	CTNNB1
Gastrointestinal Stromal Tumors	1/323	0.07819084077928928	0.08605067835324631	0	0	15.274068322981366	38.92753274356811	CDH1
Obesity	2/1961	0.07861328206686333	0.08605067835324631	0	0	6.137825421133231	15.609807289467662	MYC;CTNNB1
Hepatitis, Toxic	1/325	0.07865926271526863	0.08605067835324631	0	0	15.17824074074074	38.59264851035018	CTNNB1
Chemical and Drug Induced Liver Injury	1/325	0.07865926271526863	0.08605067835324631	0	0	15.17824074074074	38.59264851035018	CTNNB1
Chemically-Induced Liver Toxicity	1/325	0.07865926271526863	0.08605067835324631	0	0	15.17824074074074	38.59264851035018	CTNNB1
Heart Diseases	1/325	0.07865926271526863	0.08605067835324631	0	0	15.17824074074074	38.59264851035018	MYC
Drug-Induced Acute Liver Injury	1/325	0.07865926271526863	0.08605067835324631	0	0	15.17824074074074	38.59264851035018	CTNNB1
Impaired glucose tolerance	1/326	0.07889340226138043	0.08620681150924883	0	0	15.13076923076923	38.42697422306126	RAC1
Hypertrophic Cardiomyopathy	1/328	0.07936153854748781	0.08661797552115857	0	0	15.036697247706423	38.09910277566837	MYC
Hepatitis, Drug-Induced	1/329	0.07959553530232799	0.08677293617352058	0	0	14.990091463414634	37.93688265566582	CTNNB1
Fatigue	1/330	0.07982948448493005	0.08682722476273244	0	0	14.943768996960486	37.775791208875084	CTNNB1
Secondary malignant neoplasm of bone	1/330	0.07982948448493005	0.08682722476273244	0	0	14.943768996960486	37.775791208875084	CDH1
Graves Disease	1/335	0.08099851689262026	0.08799723667020842	0	0	14.716317365269461	36.98688001917869	MYC
Thrombocytopenia	1/341	0.08239978713624344	0.08941656993035392	0	0	14.452205882352942	36.07519780927155	MUC4
Recurrent tumor	1/347	0.08379934757616297	0.09083078708542722	0	0	14.197254335260116	35.19967940045038	MYC
Uterine Fibroids	1/349	0.08426548802987102	0.09123117705185806	0	0	14.114224137931034	34.91552621279723	CTNNB1
Retinal Diseases	1/355	0.08566277118487213	0.09263760691208076	0	0	13.870762711864407	34.08513782447428	RAC1
Lymphoma, Follicular	1/359	0.08659334531316008	0.09353668342532641	0	0	13.712988826815643	33.54927023593411	MYC
Precursor B-cell lymphoblastic leukemia	1/367	0.0884522206016669	0.09543529064916692	0	0	13.407786885245901	32.51780836606193	MYC
Orbital separation excessive	1/368	0.08868436705976285	0.09557640929983584	0	0	13.370572207084468	32.39250623436721	CDH1
Hepatomegaly	1/373	0.08984438998946152	0.09671604995440891	0	0	13.1875	31.777603637520446	CTNNB1
Drug-Induced Liver Disease	1/377	0.09077155757037157	0.09760271241603237	0	0	13.044547872340425	31.299209284337966	CTNNB1
Chronic Kidney Diseases	1/380	0.0914664372624149	0.09823787054493993	0	0	12.939313984168866	30.948033546335335	RAC1
Erythrocyte Mean Corpuscular Hemoglobin Test	1/387	0.09308617115067841	0.09975029476714743	0	0	12.700129533678757	30.153024012846306	CDH1
Finding of Mean Corpuscular Hemoglobin	1/387	0.09308617115067841	0.09975029476714743	0	0	12.700129533678757	30.153024012846306	CDH1
Chronic kidney disease stage 5	1/388	0.09331737298911102	0.09988454339243098	0	0	12.666666666666666	30.04215378203062	RAC1
Ataxia Telangiectasia	1/396	0.09516529082007029	0.10174701728268286	0	0	12.405063291139241	29.178445518646296	MUC4
Rhabdomyosarcoma	1/397	0.0953960685425698	0.10187824760548508	0	0	12.37310606060606	29.073308933012967	MYC
Strabismus	1/404	0.0970101944459733	0.10348485674496925	0	0	12.153846153846153	28.35418422784221	CTNNB1
Dermatologic disorders	1/406	0.0974709498073476	0.10385887646138846	0	0	12.092592592592593	28.153984909863365	RAC1
Burkitt Lymphoma	1/407	0.09770125695661641	0.1039867780023581	0	0	12.062192118226601	28.054739223931737	MYC
Retinitis Pigmentosa	1/410	0.09839189630527044	0.10460378603818492	0	0	11.971882640586797	27.760363551280037	MYC
Metastatic melanoma	1/417	0.1000017436121233	0.10619554529981111	0	0	11.766225961538462	27.09253134428423	MYC
Cardiomyopathy, Dilated	1/419	0.10046127735607754	0.10656353717298214	0	0	11.708732057416269	26.90646634918319	RAC1
Benign Prostatic Hyperplasia	1/420	0.10069097383003282	0.1066871778895741	0	0	11.680190930787589	26.814204012447785	MYC
Metabolic Diseases	1/421	0.10092062338018455	0.10681049141135132	0	0	11.651785714285714	26.72244979127093	CTNNB1
Kidney Failure, Chronic	1/437	0.10458864035684387	0.11056848414406253	0	0	11.215022935779816	25.32038532887768	RAC1
Osteoporosis	1/441	0.10550377136579794	0.1114110373997172	0	0	11.110795454545455	24.988274298585058	MYC
Fatty Liver	1/443	0.10596105619743108	0.11164388379237711	0	0	11.059389140271493	24.824829946098845	MYC
Childhood Acute Lymphoblastic Leukemia	1/443	0.10596105619743108	0.11164388379237711	0	0	11.059389140271493	24.824829946098845	MYC
Eczema	1/454	0.10847278106527652	0.11416275953633456	0	0	10.78476821192053	23.95573113418895	CDH1
Malaria	1/469	0.11188875961933137	0.11762664472801504	0	0	10.431089743589743	22.84669555156195	MYC
Malignant Head and Neck Neoplasm	1/470	0.11211611867908552	0.11773440970420673	0	0	10.408315565031982	22.775686063928468	RAC1
Acute Promyelocytic Leukemia	1/475	0.11325221560449328	0.11879514940493566	0	0	10.295886075949367	22.425860200927804	MYC
Acute leukemia	1/492	0.11710624941080804	0.12270132577154663	0	0	9.930753564154786	21.298225410751762	MYC
Adult T-Cell Lymphoma/Leukemia	1/500	0.11891526936765551	0.12445848947136422	0	0	9.76753507014028	20.798442798066006	MYC
Herpes Simplex Infections	1/503	0.11959288685742771	0.12502892716912897	0	0	9.707669322709163	20.615807611144984	MUC4
Malignant Glioma	1/504	0.11981866668203833	0.12512624881634787	0	0	9.687872763419483	20.555493886632224	RAC1
Genetic Diseases, Inborn	1/507	0.12049572825682751	0.12569410591392516	0	0	9.628952569169961	20.37622109557891	CTNNB1
Intellectual Disability	2/2503	0.12095751041457752	0.12603638930491337	0	0	4.663201386112222	9.85015465966465	CTNNB1;RAC1
Major Depressive Disorder	1/513	0.12184860145776817	0.12682475847094415	0	0	9.51318359375	20.02502292534836	RAC1
Unipolar Depression	1/517	0.12274959165818694	0.12762168129401355	0	0	9.4375	19.796183417369683	RAC1
Lymphoma, Non-Hodgkin	1/539	0.12769182803540774	0.1326138698649664	0	0	9.04135687732342	18.60833766090619	MYC
Diabetic Nephropathy	1/561	0.13261176460090965	0.13757194061458505	0	0	8.676339285714286	17.529064060711168	CTNNB1
Systemic Scleroderma	1/562	0.13283486945760276	0.13765195813024111	0	0	8.66042780748663	17.482359647877576	MYC
Steatohepatitis	1/569	0.13439531832750984	0.1391161198494421	0	0	8.550616197183098	17.16082749900153	MYC
Small head	1/570	0.13461805610235902	0.139193889149698	0	0	8.535149384885765	17.115652201240703	CTNNB1
Mental Depression	1/575	0.13573105725617002	0.14019100437302115	0	0	8.45862369337979	16.892547116915452	RAC1
Hodgkin Disease	1/592	0.13950669836431306	0.1439330596909707	0	0	8.208121827411167	16.16706692554693	MYC
Cystic Fibrosis	1/594	0.13995002251638428	0.1442326461562299	0	0	8.179595278246206	16.084927926291456	MUC4
Colitis	1/608	0.14304817791040506	0.14726466350383402	0	0	7.9851729818780885	15.527758145062677	RAC1
Precursor Cell Lymphoblastic Leukemia Lymphoma	1/618	0.14525567465450331	0.14937415616051977	0	0	7.851701782820097	15.147972735427741	MYC
Huntington Disease	1/627	0.14723852998927164	0.15124829387786837	0	0	7.735223642172524	14.81837840707764	RAC1
Generalized hypotonia	1/633	0.14855838788938064	0.15243804110956033	0	0	7.659414556962025	14.604797146546398	CTNNB1
Kidney Diseases	1/639	0.1498766110596996	0.15362352633619208	0	0	7.585031347962382	14.395956517055033	RAC1
Chronic Obstructive Airway Disease	1/669	0.15644325878150547	0.16018023130397357	0	0	7.2331586826347305	13.41795707752968	MUC4
Impaired cognition	1/671	0.1568795881979276	0.16045276753866133	0	0	7.210820895522388	13.356435691625922	RAC1
Depressive disorder	1/741	0.17203775699624121	0.17576555238077513	0	0	6.5050675675675675	11.449187635708403	RAC1
Cerebrovascular accident	1/768	0.17782587384844506	0.18148246649251484	0	0	6.267275097783572	10.82327351455758	RAC1
Liver Cirrhosis, Experimental	1/801	0.18485623068381818	0.18845343301063844	0	0	5.9984375	10.12642354840817	MYC
HIV Infections	1/806	0.18591722753103335	0.1893303947751236	0	0	5.959627329192546	10.026797155455391	MYC
Heart failure	1/815	0.1878242375946455	0.19106607988322621	0	0	5.890970515970516	9.851167550613674	RAC1
Bipolar Disorder	1/837	0.19247077573719518	0.19558183353467137	0	0	5.729366028708134	9.440912085146033	RAC1
Congestive heart failure	1/884	0.20232623459087498	0.2053752844124813	0	0	5.4110985277463195	8.646252900031213	RAC1
Coronary heart disease	1/913	0.20835909623713786	0.2112716427436785	0	0	5.231085526315789	8.204917178366577	RAC1
Dull intelligence	1/947	0.21538556399448106	0.21792766829055324	0	0	5.034090909090909	7.7289683234236835	CTNNB1
Low intelligence	1/947	0.21538556399448106	0.21792766829055324	0	0	5.034090909090909	7.7289683234236835	CTNNB1
Diabetes Mellitus, Insulin-Dependent	1/956	0.2172371341328312	0.2195655064172131	0	0	4.984293193717278	7.609848076679173	MYC
Cognitive delay	1/966	0.21929033284895483	0.22140340886141802	0	0	4.930051813471502	7.480657042105266	CTNNB1
Poor school performance	1/985	0.22317953998273674	0.22508909754408635	0	0	4.830030487804878	7.243976939762673	CTNNB1
Mental and motor retardation	1/1021	0.2305060536053059	0.23222992366431994	0	0	4.650735294117647	6.824852443970963	CTNNB1
Mental deficiency	1/1032	0.23273364912325623	0.23422393929907218	0	0	4.598448108632396	6.703896392781108	CTNNB1
Parkinson Disease	1/1064	0.2391846091165247	0.24045958038047205	0	0	4.452492944496708	6.369378435466371	RAC1
Arteriosclerosis	1/1087	0.24379437757069078	0.24483290527067242	0	0	4.3529005524861875	6.143814965889032	MYC
Global developmental delay	1/1102	0.2467886904846365	0.24757631396490665	0	0	4.290190735694823	6.002932747864151	CTNNB1
Seizures	1/1174	0.26102965220517216	0.2615844442396146	0	0	4.0115089514066495	5.387942989932423	CTNNB1
Hypertensive disease	1/1310	0.2873413052766508	0.2876463385094286	0	0	3.5687547746371275	4.450538952142365	RAC1
Asthma	1/1313	0.28791313935406276	0.28791313935406276	0	0	3.5600228658536586	4.432571810126473	CDH1
